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1. Introduction
Binuclear metallohydrolases are a structurally diverse
group of enzymes that use binuclear metal ion centers to
catalyze the hydrolysis of amides and esters of carboxylic
and phosphoric acids. Representatives are listed in Table 1,
together with their metal ion composition and, if known, their
metabolic role(s). Several of these enzymes are either targets
for drug design against a wide variety of human disorders,
including osteoporosis, cancer, cystic fibrosis, and depression,
or are of significance in bioremediation since they can be
modified to degrade pesticides or organophosphorus nerve
gases.
In 1996, Wilcox summarized the then current knowledge
about the structure, function, and mechanism of all known
binuclear metallohydrolases.1 In subsequent years more
specialized articles followed,2 focusing on the binuclear
manganese-containing arginases, catalases, and enolases,3 the
Ser/Thr protein phosphatases (in particular calcineurin),4-6
aminopeptidases,7 and the purple acid phosphatases.8-10
Despite their structural versatility and variations in metal ion
specificity (Table 1), binuclear metallohydrolases employ
variants of a similar basic mechanism. Similarities in the
first coordination sphere are found across the entire family
of enzymes (Figure 1), but in the proposed models for
catalysis, the identity of the attacking nucleophile, the
stabilization of reaction intermediates, and the relative
contribution of the metal ions vary substantially.
Here, an updated review of the current understanding of
metallohydrolase-catalyzed reactions is presented. The mo-
tivation is to present, compare, and critically assess current
models for metal ion assisted hydrolytic reaction mecha-
nisms. The focus here is on four systems, purple acid
phosphatases (PAPs), Ser/Thr protein phosphatases (PPs),
3′-5′ exonucleases, and 5′-nucleotidases (5′-NTs), which have
contributed to major advancement of our current understand-
ing of the catalytic mechanisms that operate in such enzymes.
Although three of the four enzymes (PAPs, PPs, and 5′-NTs)
are evolutionarily related,11 the enzymes selected for this
review are diverse with respect to their structure, metal ion
composition, and function. The authors have concentrated
mainly on references covering the past decade; however,
relevant earlier literature is included where appropriate. We
extend our apologies to researchers whose contributions may
not have been covered by this review.
In terms of the catalytic mechanism, the identity of the
reaction-initiating nucleophile and the roles of the metal ions
in catalysis are addressed. Where possible, predicted struc-
tures of transition states and their stabilization are discussed.
Each description of an enzyme family concludes with an
illustration of the currently accepted model for its catalytic
mechanism. The various models proposed for the hydrolytic
reaction mechanism are compared in context with observed
variations in physicochemical and functional properties.
Similar to Wilcox’s review, this article reflects the recent
achievements of bioinorganic chemists. However, since many
binuclear metallohydrolases are targets for the development
of drugs, pesticides and anti-warfare agents, structural
biologists and those involved in drug discovery and develop-
ment will find this review useful and timely.
2. Purple Acid Phosphatases
2.1. Biochemical Characterization and Function
PAPs (E.C. 3.1.3.2) are the only binuclear metallohydro-
lases where the necessity for a heterovalent active site
(Fe(III)-M(II), where M ) Fe, Zn, or Mn) for catalysis has
been established. PAPs are glycosylated, resistant to inhibi-
tion by L-tartrate, and catalyze the hydrolysis of a broad range
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of phosphorylated substrates at acidic to neutral pH.8,10,12,13
The enzyme isolated from mammals (pig, bovine, mouse,
rat, and human14-20) is a 35 kDa monomeric protein with
an Fe(III)-Fe(II) center; the amino acid sequences of animal
PAPs are highly conserved with at least 85% identity.21 The
characteristic color of PAPs is due to a charge-transfer
transition (ìmax ) 510-560 nm;  ) 3000-4000 M-1
cm-1) in the active site from a conserved tyrosine ligand to
the ferric ion.22-24 Interestingly, mammalian PAPs can easily
(and reversibly) be oxidized to the inactive diferric form due
to the low redox potential (340 mV) of the divalent iron.25,26
It has thus been suggested that PAP activity may be regulated
in vivo by reversible oxidation/reduction of the active site.25
Oxidation of the heterovalent di-iron site is also accompanied
by a change in color from pink (ìmax ) 515 nm) to purple
(ìmax ) 560 nm).16,22,24,27-29
Plant PAPs have been extracted from red kidney bean,
soybean, sweet potato, duckweed, and tomato.30-35 Most
characterized plant PAPs are homodimers with a subunit
molecular weight of 55 kDa.30-32,35 A heterodimeric
intracellular PAP has recently been reported for tomato,33
with 63 and 57 kDa subunits. The same organism also has
two secreted, monomeric isoforms with molecular weights
of 84 and 57 kDa.34 The amino acid sequences of homo-
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dimeric plant PAPs are homologous, sharing at least 65%
identity.21 However, sequence conservation between plant
and mammalian PAPs is low (<20% sequence homology)
and is limited predominantly to residues in the catalytic
center (vide infra).21 The metal ion composition in plant
PAPs is the Fe(III)-M(II) type, where M is zinc or
manganese.30-32,35,36 Thus, while plant PAPs have a chro-
mophoric center similar to that of their animal counterparts
(ìmax ) 550 nm) their activity cannot be regulated by
reversible oxidation/reduction. Interestingly, a sequence
database search has revealed that plants contain a second
type of PAP that resembles the mammalian enzymes.21 The
metal ion composition and physiochemical properties of this
novel plant PAP have not yet been determined.
A monomeric fungal PAP has been identified in Aspergil-
lus ficuum with a molecular weight of 85 kDa.37 The metal
ion composition is unknown. No bacterial PAP has yet been
characterized, but evidence has accumulated that indicates
the occurrence of this enzyme in only a limited number of
microorganisms.38
The proposed biological roles for PAP are diverse and
dependent on the organism. Mammalian PAPs have been
implicated in iron transport during pregnancy39 and macro-
phage-specific generation of reactive oxygen species (ROS)
through Fenton chemistry in response to the invasion of the
host organism by pathogens.40-42 Of particular interest is the
observation that, in animals, PAP is secreted into the bone-
resorptive space where it may be required for normal bone
turnover.10 PAP levels are elevated in patients with metabolic
bone diseases such as osteoporosis and cancers with bone
metastases.43 A transgenic mouse in which the enzyme is
overexpressed44 exhibits increased bone resorption leading
to a mild form of osteoporosis, while the transgenic mouse
knock-out45 exhibits the opposite phenotype (osteopetrosis).
It has been speculated that PAP participates in bone
resorption by dephosphorylation of bone matrix proteins such
as osteopontin.46 Because of its high expression levels, PAP
has become the most commonly used histochemical marker
for osteoporosis,10 making it a major target for the develop-
ment of chemotherapeutic agents.47
Although only one PAP-encoding gene has been identified
in mammals48,49 two isoforms have been observed, 5a and
5b.50,51 The 5a isoform represents the intact polypeptide
chain, while isoform 5b is the product of a proteolytic
cleavage in an exposed loop, sometimes referred to as the
repression loop, close to the active site.10,52-57 Since pro-
teolysis significantly increases the activity of the enzyme, it
has been proposed that isoform 5a, expressed in osteoclasts,
effectively represents a proenzyme which, upon secretion
into the bone-resorptive space, is activated by proteolytic
cleavage.52,56,57 Importantly, proteolytic cleavage does not
only increase the reactivity of PAP but also alters its
preference for substrates. In particular, since the cleaved
isoform efficiently catalyses the dephosphorylation of ATP,
whereas the intact enzyme displays a preference for ADP,56
it has been proposed that isoform 5b may act as an ATPase.
Plant PAPs may play a crucial role in mobilizing organic
phosphate esters in the soil during germination.58 However,
the study of the physiological function(s) of plant PAPs is
greatly complicated by the fact that plants contain a multitude
of genes encoding different isoforms of this enzyme.21 For
example, Arabidopsis thaliana was shown to have at least
29 different isoforms.59 Evidence has accumulated which
suggests that different isoforms may be expressed in different
tissue types in response to a variety of environmental
factors.60,61 In tomato, phosphate starvation induces the
expression of one intracellular and two secreted PAPs.33,34
Interestingly, in addition to acid phosphatase activity, each
of these isoforms can also act as an alkaline peroxidase. It
has been hypothesized that PAPs with peroxidase activity
may be involved in the generation of ROS,33,34 and that the
extracellular production of ROS is associated with the
oxidative burst that occurs during the plant’s response to
pathogen attack,34 while the intracellular ROS production
may be connected to an increase in respiratory electron
transport and O2 uptake during biotic and abiotic stresses.33
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2.2. Structural Characterization
Over the past decade crystal structures of PAPs from red
kidney bean,62,63 sweet potato,64 pig,65 rat,66,67 and human68
have been reported. To date, only structures of the inactive
oxidized state have been determined for mammalian PAPs.
The two subunits in the plant PAPs are linked via a disulfide
bridge. Each subunit has an N-terminal domain of unknown
function and a C-terminal domain that contains the catalyti-
cally active site (Figure 2).62-64 In contrast, the animal
enzymes have a single domain, which is structurally related
to the C-terminal domain of plant PAPs (Figure 2).65-68 The
active site is formed by loops at the ends of â-strands in the
middle of a R-â-â-R cluster in both plant and mammalian
PAPs. Despite the low overall sequence homology between
PAPs from these two kingdoms, the seven metal-ligating
amino acids in their active sites are invariant (Figure 3).8,21
The equivalence of their active site structures has also been
demonstrated by metal ion replacement studies which have
shown that the Zn(II)-derivatives of pig, bovine, rat, and
human PAPs are kinetically indistinguishable from the native
di-iron forms,28,53,54,69-72 while the di-iron derivative of red
kidney bean PAP has properties very similar to those of the
native Fe(III)-Zn(II) form.73,74 Furthermore, spectroscopic
and magnetochemical measurements also support similar
active site geometries and properties. The di-iron derivative
of red kidney bean PAP is redox-active and has an anti-
ferromagnetically coupled binuclear center with an exchange
coupling constant (2jJj  10-20 cm-1) similar to that
determined for the animal enzymes.29,75 Also, 1H NMR
studies of the di-iron derivative of the red kidney bean
enzyme and native mammalian enzymes provided strong
evidence that the coordination environment of the chro-
mophoric Fe(III) centers is very similar in both systems, an
observation also supported by comparable charge-transfer
Table 1. Representative Group of Binuclear Hydrolytic Enzymesa
enzyme metal center metabolic role(s) pharmacology
purple acid phosphatases* Fe(III)-Fe(II); bone resorption, iron transport, target for anti-
Fe(III)-Zn(II); generation of reactive osteoporotic drugs
Fe(III)-Mn(II) O2 species
Ser/Thr phosphatases*b Fe(II)-Fe(II); glycogen metabolism, muscle targets for
Fe(II)-Zn(II); contraction, signal transduction, development of
Mn(II)-Mn(II) neuronal activities, cell cycle immunosuppressants
progression, RNA splicing
ureases Ni(II)-Ni(II) hydrolysis of urea target for pesticides and drugs
against pyelonephritis, kidney stones,
and peptic ulcers
leucine aminopeptidase Zn(II)-Zn(II) protein degradation,
amino acid biosynthesis
target for drugs against myeloid leukemia,
cystic fibrosis, and eye lens aging
3′-5′ exonucleases* Mn(II)-Mn(II) correction of errors during
DNA replication
EcoRV endonuclease Mg(II)-Mg(II) DNA metabolism
5′-nucleotidases*b Zn(II)-Zn(II); maintenance of balanced
Co(II)-Co(II) nucleotide concentrations
phosphotriesteraseb Zn(II)-Zn(II); removal of organophosphates target for development of
Cd(II)-Cd(II); as response to toxic stress biocatalyst to remove
Zn(II)-Cd(II); organophosphorus nerve agents
Co(II)-Co(II) (e.g., Sarin)
metallo-â-lactamases Fe(II)-Fe(II); virulence factors potential antibiotic
Zn(II)-Zn(II) and/or vaccine targets
inositol monophosphatase Mg(II)-Mg(II) signal transduction target for development of drugs against
manic-depressive disorders
a Metal ion compositions, metabolic roles, and pharmacological potential are indicated. The “*” indicates systems that are discussed in detail in
this review. b The in vivo metal ion composition for these enzymes is not established.
Figure 1. Diversity of proposed mechanisms for binuclear metallohydrolases. (A) Purple acid phosphatase, (B) urease, (C) leucine amino-
peptidase, (D) alkaline phosphatase, (E) 3′-5′ exonuclease, (F) inositol monophosphatase, (G) phosphotriesterase, and (H) EcoRV endonuclease.
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transitions in the visible region.76 The Fe(III) site in PAPs
is coordinated to the oxygen of a deprotonated tyrosine, the
nitrogen atom of a histidine, and the oxygen atoms of two
aspartate residues, one of which bridges the two metal sites
(Figure 4). Although no binding constants have been
reported, metal ion replacement studies indicate that Fe(III)
is tightly bound.28,53,54,70,72,73,77-80 The divalent metal site
(Zn(II), Fe(II), Mn(II)) is coordinated to the oxygen atom
of the bridging aspartate, the nitrogen atoms of two histidine
residues, and an asparagine oxygen atom. Its binding affinity
is reduced compared to Fe(III), enabling the generation of
mononuclear, inactive Fe(III) half-apoenzymes.28,73,79 A
property observed among many binuclear metalloenzymes
is the presence of a high- and low-affinity binding site for
the metal ions (see also below). For comparative purposes,
the high-affinity site is labeled M1, while the low-affinity
site is M2 (Figure 4). The crystallographic metal-metal
distances are in the range 3.1-3.3 Å for red kidney bean
PAP (Fe(III)-Zn(II)), 3.3 Å for the Fe(III)-Mn(II) center
in the sweet potato PAP, and 3.1-3.5 Å for mammalian
PAPs, in agreement with extended X-ray absorption fine
structure (EXAFS) studies, which determined metal-metal
distances for the Zn(II) derivatives of pig PAP in the range
3.2-3.3 Å.81,82
The presence or absence of terminal and bridging aqua/
hydroxo ligands and the protonation state of the bridging
water molecule have been points of some conjecture. The
initial structure of red kidney bean PAP revealed no evidence
of water molecules in the first coordination sphere of the
two metal ions due to the limited resolution of the crystal-
lographic data.62,63 To account for spectroscopic, kinetic, and
magnetochemical data29,83-85 the coordination environments
of the Fe(III) and Zn(II) were completed by modeling a
hydroxide ligand bound to the Fe(III), a H2O ligand to Zn(II),
and a bridging hydroxide (Figure 4).62,63 The presence of a
bridging oxygen atom was subsequently observed in the
electron density maps for pig and rat PAP, which were
interpreted in terms of a hydroxide group.65,67 The pig PAP
structure also contains a phosphate ion bridging the two metal
sites,65 while in the rat PAP structure, a sulfate anion is bound
monodentately to the redox-active iron.67 Pulsed electron-
nuclear double resonance (ENDOR) and EXAFS studies of
the Fe(III)-Fe(II) and Fe(III)-Zn(II) forms of pig PAP have
since confirmed the presence of the bridging hydroxide
ligand in the resting state.81,86 In addition, ENDOR measure-
ments have also supported the presence of a water ligand,
coordinated terminally to the redox-active divalent metal ion.
However, in the same study, no evidence for a terminal,
Fe(III)-bound water molecule was found for the resting
enzyme, suggesting that the trivalent metal ion is five-
coordinate.86 This observation contrasts with crystallographic
data reported for rat PAP, where an area of electron density
associated with the Fe(III) site has been assigned to a terminal
solvent (H2O/OH) molecule.67 However, the sulfate ion
bound at the Fe(II) site in this structure may be partially
responsible for recruiting this solvent molecule.
The pKa for the protonation equilibrium of the bridging
water ligand depends on the metal ion composition. Mag-
netization and electron paramagnetic resonance (EPR) mea-
surements have indicated that the Fe(III)-Fe(II) center in
pig PAP is weakly antiferromagnetically coupled at pH 4.9,
while the Fe(III)-Mn(II) center in the sweet potato enzyme
is strongly coupled at this pH.29,36 These observations have
been interpreted in terms of the presence of a í-hydroxo
bridge in the mammalian PAPs and a í-oxo bridge in the
sweet potato enzyme at that pH.36,64
To date, most crystal structures of PAPs have been
determined in the presence of the tetraoxoanions, phos-
phate,63-66,68 tungstate,63 or sulfate,67 bound to the active site.
The structure of the phosphate complexes in red kidney bean,
pig, rat, and human PAPs all show a í-Ł1-Ł1-PO43- coor-
dination mode87 with the phosphorus approximately equi-
distant from the two Fe sites, although limited resolution
precluded the establishment of the proper orientation of the
phosphate in the structure of the rat enzyme.66 In these
structures, the phosphate ion is invariably involved in an
extensive network of hydrogen bonds and is assumed to be
coordinated in the protonated H2PO4- state, reflecting the
pH conditions under which the proteins were crystallized
(pH 4.5, 5, 6.4, and 6-6.5 for the red kidney bean, pig, rat,
and human enzymes, respectively). The structure of pig PAP,
resolved to 1.55 Å,65 shows that the uncoordinated oxygen
atoms of the phosphate group form hydrogen bonds with
His195(296) (2.76 Å) and His92(202) (2.68 Å), while the
Figure 2. Ribbon representation of the overall structure of PAPs
from (A) sweet potato (PDB code 1XZW), and (B) pig (PDB code
1UTE). Sweet potato PAP is homodimeric; each subunit contains
two domains, an N-terminal domain (in blue) of unknown function
and a catalytic C-terminal domain (in magenta). The structure was
solved complexed with phosphate (not shown). The metal ions are
colored orange for Fe(III) and blue for Mn(II). Mammalian PAPs
are monomeric and contain only one domain. In panel B, the two
Fe ions are shown as orange spheres and the bound phosphate is
shown as a stick model.
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two coordinated oxygen atoms interact with His92(202) (3.17
Å), Asp52(164) (3.04 Å), and His223(325) (3.13 Å) as well
as with the í-hydroxy bridge (the residue numbers in
parentheses refer to the sequence of red kidney bean PAP).
In red kidney bean PAP, tungstate coordinates to the metal
centers in a mode similar to that of phosphate (í-Ł1-Ł1-
WO42-) with a series of hydrogen bond contacts to the
four residues, His323(221), His296(195), His202(92), and
Asn201(91) (the numbers in parentheses refer to the sequence
of pig PAP).63 No large conformational changes are observed
in the active site of red kidney bean PAP upon binding of
phosphate and tungstate; superposition of the active sites of
the resting and both the phosphate- and tungstate-bound
forms reveal minor orientation differences for His295 and
His296 (only the latter residue is conserved throughout
PAPs).63
The observed í-Ł2-Ł2-H2PO4- coordination mode in sweet
potato PAP is unique among PAP structures.64 One oxygen
atom of the bound phosphate anion (O2) acts as a bridge
between the Fe(III) and Mn(II) ions; O1 and O3 complete
the coordination environment of the two six-coordinate metal
ions. The protonation state of phosphate (H2PO4-) is defined
by the hydrogen bonds which are distributed differently in
two subunits of the molecule. In one subunit, O3 and O4
(uncoordinated oxygen atom) are protonated, while in the
other, O1 and O3 are protonated, demonstrating structural
flexibility.64 A similar í-Ł2-Ł2-H2PO4- mode of coordination
has only been observed in the phosphate complex of the di-
Ni(II) urease from Bacillus pasteurii.88 Related coordination
modes have been reported for í-Ł2-Ł2-CO32- complexes of
iron, cobalt, nickel, copper, and zinc,87,89-91 as well as for
the í-Ł2-Ł2-SO42- complex of the Mn(II)-Mn(II) bacte-
riophage ì protein phosphatase (ìPP).92
The structure of rat PAP has also been determined in the
presence of sulfate,67 which coordinates monodentately to
the redox-active iron and forms hydrogen bonds with Asn91
and His92. Both metal ions in the active site have six ligands,
with one Fe(III)-bound and one bridging water ligand
completing their first coordination spheres. The location of
the sulfate group relative to the binuclear metal center is
further stabilized through interactions with an adventitiously
bound Zn(II) (present in the crystallization solution). Red
kidney bean PAP was crystallized recently in the presence
of sulfate but absence of Zn(II) in the buffer (Guddat, L.
W., and Schenk, G., unpublished results); interestingly,
sulfate does not coordinate to the binuclear center but forms
a number of strong hydrogen bonds in the second coordina-
tion sphere, including one to the bridging water molecule.
Depending on the source and/or tissue type from which
mammalian PAPs are extracted, they are either monomers
of 35 kDa (isoform 5a) or heterodimers with disulfide-
linked 20 and 16 kDa fragments (isoform 5b; vide supra).
The crystal structures of intact pig and rat PAP,65,67 in
combination with N-terminal amino acid sequencing and
mass spectrometry, have identified an exposed loop that is
susceptible to proteolytic cleavage.52,54,56,57 Several proteases
(trypsin, papain, cathepsins K and L) have been shown to
cleave within this loop; generally, the nicked enzyme has
significantly increased reactivity, but this increase appears
to be protease-dependent.52,57 Substrate specificity and the
pH dependence of kinetic parameters are also altered upon
proteolysis.52,54,56 Site-directed mutagenesis studies have
identified loop residues Ser145 and Asp146 in rat PAP as
important contributors to the regulation of enzyme activ-
ity.53,57 A similar role for these residues has also been
proposed for the human enzyme.54 In addition, the observa-
Figure 3. Partial sequence alignment of PAPs from different kingdoms and sources. Only the five conserved motifs containing the seven
metal ion-coordinating residues (in bold) are shown.21 The number of amino acid residues separating the motifs and the total sequence
lengths are indicated.
Figure 4. Active site of red kidney bean PAP. Fe(III) binds to the
high-affinity metal site M1, and Zn(II) is bound to the low-affinity
site M2. The seven metal ion-coordinating residues and the two
histidines (His202 and His296) are highly conserved among PAPs
from different sources. Tyr167 forms a charge-transfer complex
with Fe(III).
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tion that the mode of fluoride inhibition is uncompetitive at
pH 4.9 or above but noncompetitive at lower pH values has
been interpreted in terms of a regulatory role for a second
aspartate residue in the loop (Asp158), at least in human
PAP.56 Because of its role in the regulation of enzyme
activity, the exposed loop is commonly referred to as
“repression” loop. Its structural flexibility has recently been
demonstrated by a comparison of two structures of intact
(uncleaved) human PAP.68 The recombinant enzyme ex-
pressed in Pichia pastoris has an overall and active site
structure similar to that of other PAPs, with the two metal
ions linked via both a phosphate and a í-hydroxo bridge. In
contrast, human PAP expressed in Escherichia coli crystal-
lizes in a distinctly different manner. Here, Asp145 (corre-
sponding to Asp147 in rat PAP) bidentately coordinates to
the metal ions in the active site, occupying a position
equivalent to that of the phosphate group in pig PAP and
the human enzyme expressed in P. pastoris.65,68 Furthermore,
Asn89 (Asn91 and 201 in pig and red kidney bean PAPs,
respectively; Figure 4) is prevented from coordinating to the
redox-active iron due to steric interactions with the loop
residue Asn143; an additional water molecule completes the
first coordination sphere instead.68 There is no space for
substrate binding in this closed conformation of the active
site, and thus, the enzyme is expected to be catalytically
inactive. Thus, the two structures of human PAP are believed
to represent an active, open and an inactive, closed form of
the intact enzyme.68 Upon proteolytic cleavage, the equilib-
rium between the two forms might be altered in favor of the
active, open form, explaining the observed activation by
proteolysis. The presence of the equilibrium between open
and closed forms is supported by the observation that the
Fe(III)-Zn(II) derivative of human PAP is insensitive toward
proteolysis; the enzyme is always in the active state,72 which
indicates that metal ion substitution shifts the equilibrium
toward the open conformation, possibly due to the inability
of Asp145 to form a í-carboxylate complex. However,
further studies (e.g., using site-directed mutagenesis) are
necessary to assess the physiological relevance of the
inhibitory, closed form of animal PAPs.
2.3. Catalytic Mechanism
The observation of both an apparent lack of a burst of
product formation and the absence of enzyme-catalyzed
transphosphorylation,93 and the measurements of kinetic and
solvent isotope effects,94 supported by isotope labeling95 and
site-directed mutagenesis studies,96 have led to the emergence
of a mechanistic model for PAPs and PPs that invokes a
direct transfer of the phosphoryl group of the substrate to a
metal-coordinated, nucleophilic solvent molecule.
In the initial step of the catalytic cycle (Figure 5), substrate
binds to the divalent metal ion (site M2; Figure 4), facilitated
by the rapid exchange of the bound water ligand.79,85 It is
uncertain if the substrate binds in a mono- or bidentate
manner to the active site prior to hydrolysis. For the Fe(III)-
Zn(II) derivative of bovine PAP, it was shown that the
addition of the reaction product (and inhibitor) phosphate
does not affect the spectroscopic properties of the trivalent
metal ion greatly at the pH of optimal activity (pH 6.5),
suggesting monodentate binding to the divalent metal ion.70
In contrast, at lower pH phosphate perturbs the Fe(III) site,
consistent with the formation of a í-phosphate complex.70
A similar observation has been reported for a proteolytically
cleaved human PAP (pH optimum at 6.3), whereas in the
intact enzyme, phosphate may not directly coordinate to the
metal center, possibly because the majority of active sites is
in the closed conformation.97 In contrast, pig PAP has a more
acidic pH optimum (pH  5),47,85 and based on a combination
of EPR, EXAFS, and resonance Raman spectroscopic data,
it has been proposed that in this enzyme phosphate adopts a
bidentate coordination geometry at that pH.81,82,98,99 Thus, it
is possible that the precise substrate coordination may be
pH-dependent.
Another point of conjecture is the identity of the reaction-
initiating nucleophile (Figure 5). Metal ion replacement
studies demonstrated that the nucleophile is bound to the
trivalent metal ion.77,78 Initially, for both pig and red kidney
bean PAPs, it was suggested that the hydroxide terminally
Figure 5. Proposed mechanism of hydrolysis by PAPs. (A)
Substrate binding; (B) nucleophilic attack and release of leaving
group; (C) regeneration of the active site; phosphate is replaced by
two or three water molecules (see text for details).
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bound to Fe(III) attacks the substrate, leading to the release
of the product alcohol and the formation of a í-phosphate
complex in the active site.9,79 However, the observation (by
ENDOR) that no terminal Fe(III)-bound hydroxide group
may be present in the resting state of pig PAP argues against
this (although the possibility that substrate binding may
promote the binding of a water molecule to Fe(III) cannot
be ruled out at present).86 It could also be shown that fluoride
can replace the bridging hydroxide group in pig PAP.99 Upon
the further addition of phosphate, a ternary PAPâFâPO4
complex was formed, where phosphate binds to both metal
ions, as observed in the crystal structure of pig PAP.65 Thus,
in this instance, fluoride has been proposed to replace the
bridging nucleophile.71,99 This hypothesis is in agreement
with the crystal structure of the manganese-containing sweet
potato PAP, where the bridging water molecule has been
replaced by an oxygen atom of the bound phosphate group,64
and recent fluoride inhibition studies of human PAP.56,97,100
The precise nature of the transition state of PAP-catalyzed
reactions may vary between enzymes from different sources,
or different isoforms from the same source. Both pig and
red kidney bean PAPs display a similar Brønsted correlation
with âlg  -0.4.64 The maximum value of âlg for the
hydrolysis of a dianionic monoester is -1.3,101 indicative
of a dissociative mechanism. While the small âlg of -0.4 in
pig and red kidney bean PAPs is not unambiguously
consistent with such a mechanism, it is in contrast to the
absence of a Brønsted correlation in sweet potato PAP, which
has been interpreted in terms of an associative mechanism
(i.e., bond formation between the nucleophile and the
phosphorus atom occurs prior to hydrolysis; Figure 6).64
Interestingly, neither intact nor cleaved human PAP displays
a significant Brønsted correlation, suggesting a transition state
similar to that of the sweet potato enzyme.56 In addition, the
observation that both intact and cleaved human PAPs appear
to have similar transition states supports the regulatory model
described above, whereby the intact enzyme exists in
equilibrium between inactive, closed and active, open
conformations.68
Since the electron-withdrawing potential of the leaving
group affects the reactivities measured for both pig and red
kidney bean PAPs, the rate-determining step in catalysis is
likely to be associated with hydrolysis.64,93 At first glance,
the lack of a Brønsted correlation in the sweet potato and
human enzymes may indicate that the rate-limiting step
occurs after hydrolysis. However, an analysis of the structure
of sweet potato PAP has revealed that an associative
transition state is likely to be stabilized by the tripodal
coordination of the oxyphosphorane, which leads to effective
charge neutralization.64 Furthermore, leaving group pro-
tonation by residue Glu365 may also contribute to the relative
insensitivity of the sweet potato enzyme toward the leaving
group pKa.64 The fact that Glu365 is not conserved among
PAPs explains observed mechanistic variations. However,
in human PAP, similar to the sweet potato enzyme, the
associative transition state may be stabilized via residue
Asp158, located in the flexible repression loop.56 Notably,
both sweet potato and proteolytically cleaved human PAPs
have considerably higher substrate turnover rates than other
PAPs, especially at lower pH. This has been interpreted in
terms of Glu365 and Asp158 acting as proton donors for
the leaving groups, at least at low pH.56,64 At higher pH, a
conserved histidine residue (His195, His195, His296, and
His295 in pig, human, red kidney bean, and sweet potato
PAPs, respectively (Figure 4)), is the likely proton donor
(Figure 5).63-65,67,80 The significance of this histidine residue
has been demonstrated by site-directed mutagenesis studies
of rat PAP where its replacement by alanine and glutamine
leads to a drastic drop in reactivity.41 A second histidine
residue in the active site (His92 or 202 in pig and red kidney
bean PAPs, respectively; Figure 4) is not likely to act as
proton donor, but mutations of this residue to alanine,
asparagine, or arginine in rat and red kidney bean PAPs
support a model where it plays an important part in the
optimal orientation of both the nucleophile and the substrate
during catalysis.80,102
In the final step of the catalytic cycle (Figure 5), the bound
phosphate group is displaced, and at least two water
molecules from the solvent are required to regenerate the
active site for another catalytic cycle.64,103
2.4. Biomimetics of PAPs
In recent years, considerable attention has been devoted
toward the synthesis, X-ray structures, and physicochemical
characterization of binuclear Fe(III)-M(II) complexes to
mimic the active site of purple acid phosphatase.104 Studies
on these synthetic analogues are a convenient strategy to gain
insight into structural and spectroscopic properties and the
catalytic mechanism of the corresponding metalloenzymes.
Construction of accurate synthetic unsymmetrical models is
not a simple matter, since considerable attention must be
given to ligand design in order to achieve a coordination
environment which is similar to that imposed by the unique
topology of the protein. Often, synthetic models are binuclear
complexes containing symmetrical ligands, since the prepa-
ration of the ligands is greatly simplified.105-107 However,
unsymmetrical ligands presenting two potentially different
coordination environments allow the generation of hetero-
binuclear Fe(III)-M(II) complexes.108,109 Such systems
include a single terminal Fe-Ophenolate bond which is crucial
in mimicking structural, spectroscopic, electrochemical, and
catalytic properties of PAPs.
The H2L ligand (where L ) 2-bis[{(2-pyridyl-methyl)-
aminomethyl}-6-{(2-hydroxy-benzyl)-(2-pyridyl-methyl)}-
aminomethyl]-4-methyl-phenol; Figure 7) is able to selec-
tively generate homo- and heterobinuclear [Fe(III)(í-OAc)2(í-
phenoxide)M(II)]+ complexes when the reactions are carried
out with stoichiometric amounts of H2L, Fe(ClO4)3â9H2O,
Figure 6. Proposed transition state in sweet potato PAP. An
associative mechanism is promoted via transition state stabilization
by His295 and Glu365.64
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and M(ClO4)2â6H2O in CH3OH in the presence of sodium
acetate.108-114
The crystal structures of the mixed-valence Fe(III)-M(II)
complexes show that the Fe(III) ion is coordinated by the
tridentate hard site of L2- which contains the terminal
phenolate, while the M(II) ion lies in the other tridentate
compartment containing the soft pyridyl groups (Figure 7).
In all of the structures, the metals are in distorted octahedral
environments, separated by 3.5 Å and are bridged by two
exogeneous carboxylate groups and the central phenolate
ligand (Figure 7). As an illustration, the crystal structure of
[LFe(III)(í-OAc)2Cu(II)]+ is shown in Figure 8.112
The principal physicochemical properties including elec-
tronic spectra and electrochemical data and protonation
constants for the [LFe(III)(í-OAc)2M(II)]+ complexes are
listed in Table 2. The electronic spectra of all complexes in
CH3CN solution show absorption maxima in the range 522-
555 nm attributed to the terminal phenolate-to-Fe(III) charge-
transfer transition. Molecular mechanics calculations and an
analysis of molecular orbitals indicate that the contribution
of the bridging oxygen phenolate to the charge-transfer
transition is negligible.114 The antiferromagnetic coupling
constant of -7.4 cm-1 for the Fe(III)-Fe(II) complex (H )
-JS1S2; S1 ) 2 and S2 ) 5/2) and the Mo¨ssbauer data (which
show isomer shift and quadrupolar splitting values typical
of coupled Fe(III) and Fe(II) ions) confirm the mixed-valence
character of the binuclear iron complex,108 and these
parameters compare very well with those observed for
reduced uteroferrin.27,29,75,115 The half-wave potential of 0.38
V versus NHE observed in the cyclic voltammogram of this
complex is ascribed to the Fe(III)Fe(II)/Fe(III)Fe(III) couple
and closely resembles the corresponding redox potential of
uteroferrin (0.344 V vs NHE26) indicating that both species
have similar Fe(II) Lewis acidities. Therefore, the binuclear
iron complex can be considered as a good synthetic analogue
for the redox properties of the metalloenzyme.
Potentiometric titrations of the complexes listed in Table
2 in water/ethanol (30:70) have revealed three proton-
ation equilibria in the pH range 4-10.108-113 It has been
proposed that upon dissolving the complexes the dissoci-
ation of the first carboxylate leads to a species described as
[(OH)Fe(III)(í-OAc)M(II)(OH2)], where the pKa1 value is
consistent with the dissociation of the Fe(III)-bound terminal
water molecule. Dissociation of the second carboxylate
bridge results in the formation of a species in which a second
water molecule is bound to the Fe(III) center and, upon its
deprotonation (pKa2), an Fe(III)(í-OH)M(II) species is
formed. Finally, deprotonation of the M(II)-bound terminal
water molecule bond (pKa3) leads to the [(OH)Fe(III)(í-
OH)M(II)(OH)] species. The distinct pKa3 values observed
for the complexes (Table 2) are in agreement with the trend
observed for the first deprotonation of the [M(II)(H2O)6]2+
complexes. Moreover, it is important to note that the pKa1
values related to the deprotonation of the Fe(III)-OH2 bond
are comparable to the pKa values determined from the acidic
limbs of the pH dependence parameters for PAPs.47,56,79,85
Figure 7. Schematic illustration of the H2L ligand. L ) 2-bis-
[{(2-pyridyl-methyl)aminomethyl}-6-{(2-hydroxy-benzyl)-(2-pyridyl-
methyl)}aminomethyl]-4-methyl-phenol.108-114
Table 2. Physicochemical Properties of PAP Mimeticsa
[Fe(III)M(II)] ìmax (nm)  (M-1 cm-1) E11/2 (V)i E21/2 (V)i pKa1 pKa2 pKa3
M(II) ) Feb 555 4560 -0.49 0.38
) Mnc 544 2680 -0.47 0.84 5.80 7.76
) Znd 540 3700 -0.51 4.84 5.99 7.97
) Cue 546 3400 -0.60 -0.90 5.25 6.20 7.82
) Nif 522 2600 -0.54 0.76 5.30 6.80 8.61
Pig PAP
Fe(III)-Fe(II)g 515 4000 0.35j
Fe(III)-Cu(II)g 545 3400
Red Kidney Bean PAP
Fe(III)-Zn(II)h 544 3200
Sweet Potato PAP
Fe(III)-Mn(II)h 560 3200
a All models have been generated using the ligand 2-bis[{(2-pyridylmethyl)aminomethyl}-6-{(2-hydroxybenzyl)(2-pyridylmethyl)}aminomethyl]-
4-methylphenol). For comparative purposes, corresponding data for PAPs are included. b From Neves et al.108 c From Karsten et al.109 d From
Lanznaster et al.113 e From Lanznaster et al.112 f From Batista et al.111 g From Twitchett et al.79 h From Schenk et al.35 i Potentials measured vs
NHE. j From Bernhardt et al.26
Figure 8. Crystal structure of the [LFe(III)(í-OAc)2Cu(II)]+
complex, showing the coordination environments of both Fe(III)
and Cu(II) metal ions.112 The following color scheme applies: red
for O, blue for N, gray for C, and white for H.
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Catalytic activities of the Fe-Mn, Fe-Zn, Fe-Cu, and
Fe-Ni complexes have been measured with the activated
substrate 2,4-bis(dinitrophenyl) phosphate (BDNPP). Kinetic
parameters are summarized in Table 3. These reactions are
strongly dependent on pH, giving rise to bell-shaped pH
versus rate profiles and pH optima in the range 6.0-
7.0.109-113 In each case, the two protonation equilibria
associated with catalytic activity are in good agreement with
the pKa1 and pKa3 determined by potentiometric titrations
(Table 2). Thus, the catalytically active species is of the type
[(OH)Fe(III)(í-OH)M(II)(OH2)]. For the Fe-Zn complex,
it has been postulated that diester hydrolysis is likely to occur
via a mechanism similar to that proposed for red kidney bean
PAP, where substrate (bound as monodentate ligand) is
activated by the divalent metal ion, followed by intra-
molecular nucleophilic attack of the terminally Fe(III)-bound
OH- group on the phosphorus atom (Figure 9A).63,113 In
contrast, a combination of mass spectrometry and EXAFS
data collected for the Fe-Cu complex has indicated that the
ferric site in the resting state of this complex may be five-
coordinate, lacking the terminal water/hydroxide ligand.112
A similar observation has been reported for the resting state
of pig PAP (see above).86 Thus, similar to pig and sweet
potato PAPs, the Fe-Cu complex is likely to employ the
bridging hydroxo/oxo group as the initiating nucleophile
(Figure 9B).36,64,86,99
3. Ser/Thr Protein Phosphatases
3.1. Biochemical Characterization and Function
The reversible phosphorylation/dephosphorylation of serine,
threonine, and tyrosine residues in proteins is a key intra-
cellular control mechanism in eukaryotes and prokaryotes
and is regulated by protein kinases and phosphatases,
respectively. Among the phosphatases are the Ser/Thr protein
phosphatases (PPs; E.C. 3.1.3.16), a large group of enzymes
that catalyze the dephosphorylation of serine and threonine
residues. Approximately 30 different PPs have been identified
in the human genome, while in the A. thaliana genome, more
than 90 have been observed.116,117 Multiple copies have also
been identified in both bacteria and archaea.118,119
There are two distinct gene families of PPs, labeled PPP
and PPM.6 Although both gene families employ a similar
catalytic strategy via a binuclear metal center, they have
different protein folds and are not evolutionarily related. It
is therefore likely that the two families have emerged as a
result of convergent evolution to produce enzymes with
similar catalytic mechanisms.120 Advances in our understand-
ing of Ser/Thr protein phosphatases-catalyzed reactions have
been greatly aided by recent investigations of the structures
and functions of two PPPs (human PP5 and bacteriophage
ìPP) and two PPMs (human PP2C and PstP/Ppp from
Mycobacterium tuberculosis). PP5 is widely expressed in
mammalian tissues and was shown (i) to convert breast
cancer cells from estrogen-dependent to estrogen-independent
phenotypes, and (ii) to inactivate an apoptosis signal regulat-
ing kinase.121,122 The precise biological role of ìPP is
unknown, while PP2C has been implicated in a number of
cellular stress response processes.123,124 There are numerous
proteins that contain PP2C-like domains. These include yeast
adenyl cyclase, SpoIIE phosphatase from Bacillus subtilis,
and mammalian mitochondrial pyruvate dehydrogenase.125
PstP/Ppp is a broad-specificity PPM domain encoded in the
M. tuberculosis genome. The role of PstP/Ppp is to dephos-
phorylate the targets of 11 Ser/Thr protein kinases which
mediate essential developmental and metabolic signals.126 In
this review, the main focus is on structural and mechanistic
studies of these four PPs.
All PPPs characterized to date share extensive sequence
and structural homology in their catalytic cores. The metal
ion coordinating amino acid side chains and most of the
catalytically relevant residues are conserved.6 Furthermore,
the six amino acid ligands of PPPs are also conserved in
other binuclear metallohydrolases including PAPs and 5′-
NTs (which have an additional tyrosine and glutamine ligand,
respectively).11 However, variations between different met-
allohydrolases, and specifically between different PPPs, exist
with respect to their metal ion compositions. For comparison,
PAPs in their active state are heterovalent (Fe(III)-M(II),
M ) Fe, Zn, or Mn (see section 2)), and while the
biologically relevant metal ion composition in 5′-NTs is at
present unknown, enzymatic activity is generally highest for
Co(II)-Co(II) derivatives (see section 5). For PPPs, the
identity of the physiologically relevant metal ions are also
uncertain. For PP2B (also known as calcineurin) and ìPP,
heterobinuclear Fe-Zn centers have been identified or
generated in vitro.96,127-129 Initial studies using a combination
of experimental techniques including EPR and reversible
reduction and oxidation by dithionite and hydrogen peroxide,
respectively, led to the suggestion that PP2B from bovine
brain may be active in the heterovalent Fe(III)-Zn(II)
state.129 A similar conclusion was reported for ìPP.130 More
recently, catalytically active PP2B was extracted under
reducing conditions, indicating that the Fe(II)-Zn(II) state
is the active species.131,132 Also, the observation that the
recombinant expression of ìPP in E. coli leads to a dramatic
increase in intracellular manganese concentrations has been
interpreted in terms of manganese being the most likely in
vivo metal ion for this enzyme.133 Gradual addition of Mn(II)
to ìPP, monitored by EPR, has demonstrated that the active
Table 3. Kinetic Parameters for the Hydrolysis of BDNPP by
PAP Mimeticsa
[Fe(III)M(II)]
Km
(M)
kcat
(s-1)
kcat/Km
(s-1 M-1) kcat/kuncat
M(II) ) Mnb 2.1  10-3 7.1  10-4 3.3  10-1 3.9  103
) Znc 8.1  10-3 1.1  10-3 1.3  10-1 6.1  103
) Cud 1.1  10-2 1.8  10-3 1.6  10-1 1.0  104
) Nie 3.8  10-3 4.4  10-4 1.2  10-1 2.4  103
a All models have been generated using the ligand 2-bis[{(2-
pyridylmethyl)aminomethyl}-6-{(2-hydroxybenzyl)(2-pyridylmethyl)}-
aminomethyl]-4-methylphenol). b From Karsten et al.109 c From Lan-
znaster et al.113 d From Lanznaster et al.112 e From Batista et al.;111
kuncat ) uncatalyzed turnover number.
Figure 9. Proposed reaction mechanisms for the hydrolysis of
BDNPP by Fe-Zn and Fe-Cu complexes, respectively. In the Fe-
Zn complex, the proposed nucleophile is terminally coordinated to
Fe(III),113 while in the Fe-Cu complex, the nucleophile is proposed
to be the metal ion bridging oxygen.112
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site has a homobinuclear Mn(II)-Mn(II) center.134,135 Similar
to PAPs, the two metal binding sites are distinguished by
considerable differences in their affinities for the metal ions,
with KD values of 2 and 160 íM, respectively.134 A recent
redox titration study of the Fe-Zn derivative of ìPP has
determined the redox potential for the Fe(III)/Fe(II) couple
to be 120 mV.136 Although it is not known if PPPs are
able to conduct hydrolytic reactions in the oxidized form,
the possibility exists that these enzymes may be regulated
in vivo by reversible oxidation/reduction, as has been
speculated for the PAPs.136 Also, it has been proposed that,
as an alternative mechanism to reconstitute enzyme activity,
only one metal ion may be present in the resting state
rendering the enzyme inactive. The second metal ion may
enter the active site upon substrate binding, thus, reconstitut-
ing a fully active enzyme.135 A similar mechanism has also
been proposed for the proofreading activity of DNA poly-
merases (see section 4).
Apart from Mn(II), ìPP can also be activated by Ni(II),137
while activity in other PPPs such as PP1 and PP2A can be
reconstituted with Mn(II), Fe(II), and Co(II).133 It appears
thus that within the group of catalytically active PPPs,
divalent metal centers are the rule, but various combinations
may occur. For instance, X-ray fluorescence and anomalous
dispersion data indicate the presence of three different metal
ions, Mn(II), Fe(II), and Zn(II), in the ratio 1:0.35:0.15 in
the active site of PP5.138
Less is known about the metal ion requirements of PPMs.
The biologically relevant metal ions are unclear, but human
PP2C is activated most efficiently by both Fe(II) and Mn(II)
and to some extent by Mg(II), while Cu(II), Ni(II), and Zn(II)
tend to inhibit enzyme activity.139 For the recently detected
Pst/Ppp from M. tuberculosis, metal ion analysis detected
only the presence of manganese; no significant quantities of
iron or zinc were found.117 Furthermore, in assays, Mg(II),
Ca(II), Ba(II), Zn(II), and Li(I) were not able to substitute
Mn(II) in vitro, even at concentrations as high as 4 mM.140
The pH optima of PPPs are at neutral to moderately
alkaline pH.6,141 An analysis of the pH dependence of the
kcat for the hydrolysis of pNPP by ìPP has indicated the
presence of at least two protonation equilibria relevant to
catalysis (pKa1  7.7, pKa2  8.6).141 The more acidic
equilibrium is likely to describe the deprotonation of a
divalent metal ion-bound water molecule, the proposed
nucleophile, while the basic limb may be associated with a
residue involved in substrate binding.141 Similar to PAPs,
PPPs display a decreasing affinity toward substrates at
increasing pH values.
For the best characterized member of the PPM family,
human PP2C, a pH dependence of kcat similar to that of the
PPPs has been reported, with pKa1  7 and pKa2  9.142,143
The pKa1 is also proposed to be associated with the
deprotonation of a metal ion-bound water molecule, while a
site-directed mutagenesis study has identified a histidine
residue (His62) as the likely group that needs to be
protonated for catalysis, possibly in order to act as a proton
donor for the leaving group.143
PPPs are inhibited by a number of tetraoxo anions to an
extent similar to that of PAPs.137,144 For instance, at their
respective optimal pH, both groups of enzymes are moder-
ately and competitively inhibited by orthophosphate (Ki 
1 mM).64,144 Both are also strongly inhibited by orthovana-
date.144,145 Since phosphate and vanadate are believed to be
substrate and transition state analogues, respectively, these
observations highlight the similarity of the mechanisms of
PAP- and PPP-catalyzed reactions, a correlation which can
be expanded to include members of the PPM family, since
PP2C is also inhibited by phosphate in a manner similar to
PPPs and PAPs.142
3.2. Structural Characterization
Crystal structures of several PPPs have been determined
over the past decade, including those for rabbit muscle
PP1146,147 and both bovine and human PP2B (calcineurin).148,149
More recently, structures for ìPP92 and PP5138 have been
reported. In general, the catalytic domains are structurally
conserved with a sequence homology ranging from 35% to
45%.150 For instance, the catalytic domain of PP5 has been
determined to 1.65 Å resolution and shows a similar overall
fold to that of PP1 and PP2B, with root-mean-square
deviations (rmsd) of 2 Å for 270 CR atoms.138 Similar to
other PPPs, PP5 has an N-terminal domain, but it is extended
to include what is known as a tetratricopeptide repeat domain
(Figure 10). Interestingly, proteolytic cleavage in this domain
leads to the removal of the three repeat motifs and a
concomitant significant increase in catalytic activity,151,152
suggesting a regulatory mechanism similar to that of mam-
malian PAPs (see section 2).
While ìPP is considerably smaller than its eukaryotic
counterparts (221 amino acid residues as compared to 330
residues for PP1 and 524 for PP2B), its three-dimensional
fold in the catalytic core is very similar to that of other
PPPs,92 with the active site located on the surface of the
protein in a shallow groove. The structure of ìPP has been
determined to 2.15 Å resolution in the presence of both
Mn(II) and sulfate.92 The metal-coordinating residues in all
PPPs characterized to date are identical, and their relative
geometries are well-conserved. The active sites of PPPs are
thus exemplified here by the structure of ìPP (Figure 11).
Figure 10. Ribbon diagram depicting the overall fold of PP5 (PDB
code 1WAO). The N-terminal tetratricopeptide repeat is circled.
Proteolytic cleavage within the repeat segment leads to significant
increase in reactivity.151,152 The two metal ions are shown as purple
spheres.
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The two metal ions are separated by 3.5 Å and, similar to
PAPs, are bridged monodentately by an oxygen atom of a
conserved aspartate (Asp49). Additional ligands to the metal
ion in site M1 are His22, Asp20, and three water molecules
(or one water molecule and a bidentately bound sulfate
ligand; Figure 11). The Mn2 site is coordinated by nitrogen
atoms from His139 and His186, and three oxygen atoms,
one of which is donated by Asn75. The remaining two
oxygens are either from a bridging water molecule and a
monodentate sulfate, or from a bidentate sulfate (Figure 11;
note that the asymmetric unit contains three enzyme mol-
ecules, in two of which sulfate binds terminally to M2 and
in one it binds in a bidentate mode). Similar to PAPs, the
two metal centers can be distinguished with respect to their
metal ion affinities.135 However, in contrast to PAPs, ìPP
displays a higher affinity in site M2 (KD(MnII)  2 íM).
The active site geometry of PP5 is in essence equivalent
to that of ìPP,138 although it is, at present, not known if the
two metal centers have different binding affinities. The
structure was solved in the presence of phosphate, which
binds in a bridging, bidentate mode to the metal ions. Overall,
the geometric arrangement in the active site of PP5 in the
presence of phosphate is very similar to that observed for
pig and red kidney bean PAPs.63,65
Structures of the resting states of ìPP and PP5 have not
yet been solved, but crystallization of ìPP in the presence
of sulfate results in two distinct active site conformations.92
In one conformation, sulfate is monodentately bound to the
site M2 metal center and a bridging water molecule ensures
six-coordinate, distorted octahedral geometries for both metal
ions (Figure 11A). This arrangement is equivalent to the
sulfate-bound structure of rat PAP (see section 2).67 Alter-
natively, sulfate is also found to bind to both metal ions in
an unusual tripodal arrangement (Figure 11B), where three
of the ligand oxygen atoms coordinate to the metal ions. This
arrangement is rare but has been observed in the phosphate-
bound structures of sweet potato PAP and the di-Ni(II) urease
from B. pasteurii.64,88 In summary, structural similarities in
the active site of PAPs and PPPs support the hypothesis that
both systems employ a similar catalytic mechanism.
PPMs are unrelated to PPPs (and PAPs) in terms of overall
structure and sequence.6 Crystals of human PP2C were
obtained in the presence of Mn(II) and phosphate. The
protein consists of two domains, an N-terminal catalytic
domain of 290 amino acid residues, and a smaller 90 residue
C-terminal domain (Figure 12). The N-terminal domain has
a central pair of â-sheets that are flanked on either side by
a pair of R-helices. The binuclear metal center is held in
place by the loops at the ends of the â-strands.125 PPPs
contain two sandwiched âRâRâ motifs with parallel â-strands
in the catalytic core. Loops at the C-terminal ends of these
parallel strands contain the ligands to the metal ions in the
active site. A similar arrangement is also observed in PPMs;
however, the two sandwiched â-sheets have an antiparallel
orientation. Recently, the crystal structure of another member
of the PPM family, the catalytic domain of resting M.
tuberculosis PstP/Ppp, has been determined to 1.95 Å.117
Despite low overall sequence homology (17%), the struc-
tural fold of the bacterial enzyme resembles that of human
PP2C, with an rmsd of 2.2 Å for all CR atoms within the
bulk of the catalytic domain. Furthermore, the residues and
solvent ligands in the immediate vicinity of the metal centers
are strictly conserved. There are, however, two striking
differences. First, the presence of an additional C-terminal
domain in human PPC2, and second, a small subdomain, or
flap, associated with the catalytic domain, has different
orientations in the two enzymes (Figure 12). Associated with
this subdomain is a third metal ion in PstP/Ppp that is not
present in PP2C.117 The specific role of the third metal ion
is unclear, but it may fulfill a regulatory function by
modulating the location of the flap relative to the binuclear
active site. The flap region may thus play a role similar to
that of the mobile loop in mammalian PAPs (see section 2).
In the active sites of resting PPMs, the metal ions are
separated by 4 Å and bridged by a water molecule (Figure
13). In addition, the increased metal-metal distance in these
enzymes in comparison to PAPs and PPPs is consistent with
a bridging aspartate residue coordinated in í-1,3 rather than
Figure 11. The active site of ìPP complexed with sulfate (PDB
code 1G5B). Sulfate binds in two different modes to the active
site, (A) monodentately to the metal ion in site M2 and (B)
tridentately, with two of its oxygen atoms forming a í-1,3 bridge
and one coordinating in í-1,1 mode.92 A similar coordination mode
has been observed for phosphate in the active site of sweet potato
PAP.64
Figure 12. Ribbon diagram depicting the overall fold of PP2C
(PDB code 1A6Q). The orientation and structure of the circled
region (flap region) varies between different PPM structures. It is
hypothesized that the location of this region relative to the binuclear
center may play an important role in the regulation of enzyme
activity.117 The two metal ions are shown as purple spheres, and
the bound phosphate is shown as a stick model.
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í-1,1 mode. Site M1 is further coordinated by four oxygen
atoms, two from conserved aspartate residues (Asp191 and
Asp229 in PstP/Ppp) and two water molecules, while site
M2 is also coordinated by a backbone carbonyl oxygen
(Gly39) and three water molecules. It is not known if the
two sites differ with respect to their metal ion affinity.
Interestingly, in PP2C, none of the oxygen atoms of bound
phosphate directly coordinate to the metal ions.125 Instead,
two oxygens form hydrogen bonds with three water ligands,
two of which are terminally bound to the metal ions and
one is bridging. Two additional hydrogen bonds between
phosphate oxygen atoms and the conserved Arg20 further
stabilize the ligand.117,125
3.3. Catalytic Mechanism
The previous discussion has illustrated that different PPPs
are likely to employ the same mechanistic strategy to catalyze
hydrolysis of phosphate ester bonds. Furthermore, the
reaction mechanism of PPPs is closely related to that of
PAPs.
In the initial step (Figure 14), substrate binds to the active
site. On the basis of steric considerations, it has been
proposed that the likely binding mode involves the formation
of a í-phosphate bridge, since this would be the least
rearrangement required to accommodate the leaving group.138
Interactions between the noncoordinating oxygen atoms of
the substrate and the positively charged, conserved residues
Arg53, Arg162, and His76 stabilize this conformation in the
enzyme-substrate complex (unless mentioned otherwise,
residue numbers are corresponding to the ìPP sequence).
In the next phase of catalysis, a nucleophilic attack on
the phosphorus atom induces hydrolysis (Figure 14). Kinetic
isotope effects and the apparent lack of phosphoenzyme
intermediates have indicated that a water molecule (hydrox-
ide) coordinated to the binuclear metal center is the only
likely nucleophile.6,94,153 In the enzyme-substrate complex
described above, the only water molecule present in the
active site is the one bridging the two metal ions (Figure
14). This is in an ideal position for an in-line attack on the
phosphorus with an O(N)-P-O(R) angle of 180° (O(N)
and O(R) are the oxygen atoms of the nucleophile and
leaving group, respectively).138 The assignment of the
bridging water molecule as the nucleophile is further
supported by the observation that its orientation relative to
the substrate is stabilized via a strong hydrogen bond to the
backbone carbonyl oxygen atom of His186, whose side chain
coordinates to the metal ion in site M2 (Figure 11). Notably,
the same hydrogen bonding interaction is also conserved in
PAPs.64,65 Another interesting correlation between PPPs and
PAPs is the unusual tripodal coordination modes for sulfate
and phosphate in the active sites of ìPP and sweet potato
PAP, respectively (Figure 11B), an observation consistent
with a role of the bridging water molecule as a nucleo-
phile.64,92
Kinetic isotope studies with ìPP and PP2B have shown
that as a consequence of the nucleophilic attack a highly
dissociative transition state is formed.141,154,155 At least in ìPP,
the cleavage of the phosphoester bond is rate-limiting.141
Hengge and co-workers have shown that the equatorial P-O
bonds in the trigonal bipyramidal transition state are strongly
polarized, a conformation that is stabilized by interactions
with the two metal ions and the conserved active site residues
Asn75, Arg53, Arg162, and His76.141 As the bond order
between the phosphorus and the oxygen atom of the leaving
group decreases, the development of negative charge on the
latter will facilitate its protonation. The most likely candidate
as a proton donor, supported by both structural and site-
directed mutagenesis studies, is His76.92,138,141
Following the decay of the transition state and the release
of the leaving group, phosphate is anticipated to remain
bound to the active site in a tripodal coordination mode, as
observed in the structures of sulfate-bound ìPP (Figure 11)
and phosphate-bound sweet potato PAP.64,92
In the final stage of catalysis, the active site has to be
regenerated for the next cycle by expulsion of the phosphate
group and the formation of a í-hydroxide bridge. His76
needs to be protonated in the process, but the identity of the
proton donor is currently unknown.
The mechanism employed by PPMs has received less
attention than that of other binuclear metallohydrolases
and is based mainly on research from Denu and co-
workers.6,142,143 In the current model, substrate binds in a
mode similar to that of phosphate in the active site (Figure
15); no direct coordination to the metal ions occurs, but the
conserved residue Arg20 assists in enhancing substrate
binding and orientation.143 In this conformation, the bridging
water molecule is proposed to be the most plausible
Figure 13. The active site of PstP/Ppp (PDB code 1TXO). Two
Mn(II) ions are present in the active site (M1 and M2). A third
manganese (M3) is observed in the flap region. The bridging
aspartate ligand coordinates in í-1,3 mode contrasting the í-1,1
mode observed in PAPs and PPPs.
Figure 14. Proposed mechanism of hydrolysis by PPPs. The
bridging water molecule between the two metal ions is in an ideal
position for a direct in-line nucleophilic attack on the phosphorus
atom of the substrate.
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nucleophile, activated via hydrogen bonding interaction with
an aspartate ligand to the metal ion in site M1 (Asp229 in
PstP/Ppp; Figure 15). From an analysis of the pH dependence
of kinetic parameters, a pKa of 7.5 is associated with this
nucleophile.142 A Brønsted correlation has shown that the
transition state of PP2C develops a moderate charge buildup,
similar to that reported for pig and red kidney bean
PAPs.64,142 This observation is consistent with a partially
dissociative mechanism. The breakage of the P-O bond is
not likely to be rate-limiting, since pre-steady-state kinetics
measurements have detected an initial product burst, followed
by a slower steady-state rate (instead, the release of phosphate
is proposed as the slowest step in the catalytic cycle).6,142
The release of the leaving group necessitates its protonation.
A recent site-directed mutagenesis study indicates that the
likely proton donor in PP2C is a histidine residue (His62 in
PP2C).143 Interestingly, although the overall structure of the
active sites of PP2C and PstP/Ppp from M. tuberculosis are
very similar, the latter does not have a histidine residue
corresponding to His62 in PP2C.117 At present, no candidate
as general acid has been identified for the reaction catalyzed
by bacterial PPMs.
4. 3′-5′ Exonucleases
4.1. Biochemical Characterization and Function
3′-5′ exonucleases (E.C. 2.7.7.7) are part of the DNA
replication process and catalyze the hydrolysis of 3′-terminal
nucleotides from single-stranded DNA, although double-
stranded DNA can also be a substrate.156-162 Their primary
role is in proofreading during replication, where misincor-
porated nucleotides will be excised (via hydrolysis of the
3′-terminal phosphodiester bond), thus, ensuring genome
integrity.163-169
In general, 3′-5′ exonucleases are a component of DNA
polymerases, large multifunctional enzymes that also contain
polymerase and 5′-3′ exonuclease activities.170-173 In most
systems studied to date, the three catalytic activities reside
in different structural domains of the same polypeptide chain.
Apart from their obvious role in DNA synthesis, DNA
polymerases from thermophiles (e.g., Thermus aquaticus)
have become a routine reagent in molecular biology, finding
application in techniques such as the polymerase chain
reaction (PCR).174,175 DNA polymerases are characterized by
a remarkably low-error frequency during replication. The
estimated mutation rate of 10-10 to 10-12 per replicated
base pair is attributed to both high-fidelity polymerase activ-
ity and low-error frequency in the proofreading process.176-179
Six classes of DNA polymerases have been identified,
distinguished by their amino acid sequences and structural
characteristics.180 These classes are labeled as E. coli DNA
polymerase I (Pol I), E. coli DNA polymerase II (Pol II,
which also includes archaebacterial and eukaryotic DNA
polymerases), E. coli DNA polymerase III (Pol III), DNA
polymerase D (found in euryarchaea), as well as families X
and Y, which lack 3′-5′ exonuclease activity.180,181
Pol III is different from other DNA polymerases, since it
contains the DNA polymerase and 3′-5′ exonuclease activites
on separate subunits.156,182 Apart from the R subunit (130
kDa), which contains the polymerase activity, and the 
subunit (28 kDa), which contains the 3′-5′ exonuclease
activity, the catalytic core of Pol III has a third component,
a small 9 kDa protein labeled the ı subunit.156,183,184 Although
its precise role is unknown at present, it has been shown
that the ı component binds to the N-terminal domain of the
 subunit.185,186 Consequently, the 3′-5′ exonuclease activity
is increased by a factor of 2. A combination of NMR and
electrospray ionization mass spectrometry has further indi-
cated that the ı subunit does not directly interfere with the
active site structure but may assist binding of substrate to
the active site of the 3′-5′ exonuclease.187,188 Additionally,
component ı also increases the thermostability of the 
subunit.189
Apart from E. coli, 3′-5′ exonucleases have been identified
in, and at least partially characterized from, various sources.
Examples are the human 3′-repair exonucleases 1 and 2
(TREX1 and TREX2);160,190 the human Werner syndrome
protein;191-193 the exonuclease components of human,
mouse, and rat p53;194 the 3′-5′ exonuclease activity of the
human metastasis suppressor NM23-H1;195 Choristoneura
fumiferana nucleopolyhedroviral 3′-repair exonuclease (V-
TREX);196 the 3′-5′ exonuclease activity associated with
apurinic/apyrimidinic endonuclease (Ape1) found in human
leukemia cells;197 E. coli exonuclease IX;198 and the 3′-5′
exonuclease activities of E. coli RNase T199 and the human
DNA damage checkpoint protein hRad9.200 Their overall
sequence homology is low, with <20% identity.201 However,
three conserved sequence motifs are recognized, termed Exo
I, Exo II, and Exo III, that contain most of the metal-
coordinating and catalytically relevant amino acid resi-
dues.158,192,202-207 Exo III generally displays greater sequence
variability than the other two motifs.
3′-5′ exonuclease activity has a strict requirement for
divalent metal ions, in particular Mg(II), Mn(II), and
Zn(II),208-211 although it is not known which metal ion is
preferred in vivo. For the  subunit of Pol III, rates of
hydrolysis are optimal in the presence of Mn(II) with a kcat
of 334 min-1 compared to a kcat of 20 min-1 for an enzyme
reconstituted with Mg(II).189 For a catalytically competent
enzyme, two metal ions are required in the active site.
Mutations that affect metal ion binding generally lead to a
significant loss in enzyme activity, as was shown by site-
directed mutagenesis experiments on various exo-
nucleases.158,212-218 For example, a mutation of the second
coordination sphere residue Asp424 to alanine in the 3′-5′
exonuclease of E. coli Pol I resulted in complete loss of
enzymatic activity, since only one metal ion was able to bind
to the active site.219
Figure 15. Proposed mechanism of hydrolysis by PPMs. The
substrate does not coordinate directly to the metal ions. Instead, it
is hydrogen-bonded to two terminal water ligands. Residue Arg20
plays a crucial role in substrate orientation. The bridging water
molecule is proposed as nucleophile and is activated through
hydrogen bonding with Asp229.
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Similar to PAPs, 3′-5′ exonucleases have a high- and low-
affinity site for the metal ions (sites M1 and M2, respectively;
see below). In the case of T4 DNA polymerase, Mg(II)
binding studies utilizing fluorescence steady-state emission
have shown a high-affinity metal binding site (KD ) 5.1 íM)
and a low-affinity site (KD ) 2.5 mM).220 Lanthanide binding
(Eu(III) and Tb(III)) to 3′-5′ exonuclease domains in T4
DNA polymerase and E. coli Pol I has been analyzed by
luminescence spectroscopy. These studies have confirmed
the presence of a high-affinity site in both systems with KD
values of 0.8 and 1.3 íM, respectively; binding affinities to
a lower affinity site could not be determined accurately.221
EPR spectroscopy has shown, for the Pol I enzyme, that sites
M1 and M2 have Mn(II) binding affinities corresponding to
KD values of 2.5 íM (tight) and 600 íM (weak), respec-
tively.222 Interestingly, the addition of the reaction product
deoxythymidine 5′-monophosphate (dTMP) increased the
affinity of site 2 100-fold, while site M1 was largely
unaffected.222 A recent Mn(II) titration of the  subunit of
E. coli Pol III (monitored by EPR) has also demonstrated a
significant variation in metal ion binding affinity for sites
M1 and M2 in this enzyme (KD ) 15 and 300 íM,
respectively) (Mitic´, N., and Schenk, G,, unpublished results).
Mn(II) can only bind to site 2 in the presence of dTMP; in
its absence, a mononuclear center is formed with Mn(II)
bound to site M1 (KD ) 10 íM). Thus, substrate/product-
induced formation of a catalytically fully active binuclear
center may be a regulatory mechanism to control proofread-
ing activity in vivo, allowing for an optimal coordination
between the processes of DNA synthesis and proofreading
(e.g., a permanently active exonuclease may affect the
selectivity of the editing process).
Most previous kinetic studies of 3′-5′ exonucleases utilized
radiolabeled single-stranded or primer-template DNA sub-
strates, the latter with mismatched 3′-termini.158,186,223,224
Assays with single-stranded DNA have shown that the 
subunit is far more reactive than the 3′-5′ exonuclease activity
of E. coli Pol I, with kcat values of 200 and 1 s-1,
respectively.158 More recently, the para-nitrophenol ester of
deoxythymidine 5′-monophosphate (pNP-dTMP) has been
used as substrate to directly monitor spectrophotometrically
the formation of the product of the hydrolytic reaction, para-
nitrophenol.189,225 In general, it has been found that the rates
of hydrolysis of pNP-TMP by various exonucleases are
significantly lower than those determined for the hydrolysis
of polynucleotide substrates. For example, kcat values reported
for the hydrolysis of pNP-TMP and single-stranded DNA
by the  subunit of DNA Pol III are 0.32 s-1 (at 25 °C and
pH ) 8.0) and 200 s-1 (pH ) 8.0), respectively.189,224 Similar
trends have been observed for the 3′-5′ exonuclease domains
of E. coli DNA Pol I and T7 DNA polymerase.225,226 A region
(residues 144-157) in T7 DNA Polymerase has been
identified as being crucial for DNA binding during catalysis.
While the deletion of this region does not affect the 3′-5′
exonuclease active site, it leads to a substantial decrease of
the hydrolytic activity in the presence of DNA substrates,
indicating that substrate binding may trigger conformational
changes required for optimal catalytic efficiency.225
A majority of 3′-5′ exonucleases have optimal activity in
alkaline environments with pH optima ranging from 7.5 to
10.2.158,189,216 The pH dependence of the Km values of the 
subunit of E. coli Pol III for the substrate pN-dTMP
associates a basic amino acid with a pKa >8.5 in substrate
interactions (possibly Arg159).189 Similarly, an analysis of
the pH dependence of enzymatic activity (kcat) indicates a
lower pKa value of 7.7 (for the  subunit of E. coli Pol III)
and 9.8 (for 3′-5′ exonuclease of E. coli Pol I) that is
associated with a mechanistically relevant protonation equi-
librium.158,189 For the  subunit, the catalytic rates for pN-
dTMP hydrolysis are 1 s-1 at pH < 6.5 and 7 s-1 at pH
> 9.0.189 The observation that this 3′-5′ exonuclease has
substantial activity even at low pH values has led to the
suggestion that, depending on the pH, a different reaction
mechanism may apply.189 Details of the mechanism of 3′-5′
exonuclease-catalyzed reactions will be discussed below.
Interestingly, recent pre-steady-state kinetic studies with
the 3′-5′ exonuclease activities of RB69 and 29 polymerase
under single turnover conditions have provided no evidence
for a pH dependence of the activity in the pH range 6.5-
8.5.227 This difference has been interpreted in terms of a rate-
limiting step preceding the excision of the 3′-terminal
nucleotide.
4.2. Structural Characterization
The first 3′-5′ exonuclease structure reported was for the
proofreading activity from E. coli DNA Pol I.172 Over the
past decade, several crystal structures of 3′-5′ exonucleases
have been determined. Among them are those from Bacillus
stearothermophilus;228 bacteriophages T7,229,230 T4,231
and RB69;232 phage 29;233 Desulfurococcus sp. Tok;234
Sulfolobus solfataricus;235 Pyrococcus kodakaraensis;236,237
T. aquaticus;238 Thermococcus sp. 9° N-7;239 and Thermo-
coccus gorgonarius.240 Recently, crystal structures of the 
subunit of E. coli Pol III and of human TREX2 have been
solved.201,241 A structural comparison reveals that despite low
sequence homology (e.g., 17% sequence identity between
the  subunit of E. coli Pol III and 3′-5′ exonuclease domain
of T4 DNA polymerase),242 their overall structural fold is
conserved with the characteristic five-stranded, antiparallel
â-sheet structure in the center surrounded by several
R-helices (Figure 16).
The active sites of most 3′-5′ exonucleases are very similar,
with four conserved carboxylate groups and a histidine or
tyrosine side chain (Figures 17 and 18), and are located in
geometrically equivalent positions. In addition, their bi-
nuclear metal centers have very similar coordination environ-
ments. The exceptions are the recently isolated and charac-
terized 3′-5′ exonuclease activities associated with DNA
polymerases of class D (see above) from Methanococcus
jannaschii243,244 and Pyrococcus horikoshii.245 Unlike 3′-5′
exonucleases from the Pol I-III classes, these enzymes
contain predominantly histidine-rich active sites, similar to
those of PPPs (Figure 11) and nucleases such as Mre11 from
Pyrococcus furiosus.246
An initial analysis showed that in the absence of a substrate
analogue or product the exonuclease active site of 3′-5′
exonuclease from Pol I contains only one metal ion. This
observation is in agreement with spectroscopic data, which
have demonstrated that the addition of dTMP to the enzyme
facilitates the formation of catalytically active binuclear
centers (see above). The crystal structure of 3′-5′ exonuclease
from Pol I, crystallized in the presence of dTMP, shows two
metal ions with different coordination geometries separated
by 3.9 Å (Figure 17B).172 Site M1 has five ligands and is
coordinated by five oxygen atoms from Asp355, Asp501,
and Glu357, the phosphate group from dTMP, and an
hydroxide group. This site has a high affinity for the metal
ion and is occupied by a metal ion even in the absence of
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dTMP (i.e., this site is equivalent to the chromophoric Fe(III)-
binding site in PAPs). Site M2 has six ligands, but only one
is from the protein. The metal ion is coordinated to six
oxygen atoms, one from the bridging Asp355, two from the
bound phosphate group of dTMP, and three from water
molecules. This site represents the low-affinity site (site M2;
equivalent to the redox-active site in mammalian PAPs).
An interesting discovery has been reported for the crystal
structure of the  subunit of E. coli Pol III, determined in
the presence of Mn(II) and dTMP at two different pH values
(pH 5.8 and 8.5; Figure 18).241 With respect to the amino
acid side chains in the active site, and the coordination
geometry of the two Mn(II) ions, the two structures are very
similar. The two metal ions are separated by 3.7 Å, and no
bridging water molecules are present. The primary differ-
ences between the two structures are the bridging mode of
dTMP and the coordination of terminal water molecules. In
the low pH structure, the Mn(II) ion in the high-affinity site
M1 has five ligands and is coordinated by five oxygen atoms,
three from Asp12, Asp167, and Glu14 and two from bound
phosphate, one of which is bridging (Figure 18B). The
coordination geometry is trigonal bipyramidal and very
similar to that of site M1 in the 3′-5′ exonuclease from E.
coli Pol I (Figure 17B). The Mn(II) in the low-affinity site
M2 has highly symmetric octahedral geometry with six
oxygen ligands, only one from the protein (the bridging
carboxylate of Asp12; Figure 18). The remaining ligands are
provided from four terminal water molecules and from the
bridging phosphate. Again, this site is very similar to the
Figure 16. Comparison of overall structure and fold of the 3′-
5′exonuclease domains from various DNA polymerases. (A) The
 subunit of bacterial DNA Pol III (PDB code 1J53); (B) human
TREX2 (PDB code 1Y97); (C) E. coli exonuclease I (PDB code
1FXX); (D) exonuclease domain of bacteriophage T4 DNA
polymerase (PDB code 1NOY); (E) human antiviral ribonuclease
ISG20 (PDB code 1WLJ); (F) exonuclease from the hyperthermo-
philic archaeon P. kodakaraensis (PDB code 1WN7); (G) exo-
nuclease domain of DNA Pol I (PDB code 2KZM); and (H)
bacteriophage …29 DNA polymerase (PDB code 1XHX). There is
a significant structural similarity of the exonuclease domain in
various DNA polymerases. The active site metal ion(s) are shown
as spheres, and the products of the exonuclease reaction (TMP and
UMP molecules) in the case of the  subunit (A) and ISG20 (E)
are shown as sticks.
Figure 17. Active site structures of various 3′-5′ exonuclease
domains. (A) Human TREX2 (PDB code 1Y97); (B) DNA Pol I
(PDB code 2KZM); (C) E. coli exonuclease I (PDB code 1FXX);
and (D) exonuclease of bacteriophage T4 DNA polymerase (PDB
code 1NOY). Three aspartate residues and one glutamate are highly
conserved among 3′-5′ exonucleases and coordinate to the two
divalent metal ions in the active site. Additionally, active sites
generally contain a conserved tyrosine or histidine residue which
does not act as a ligand but plays an important role in catalysis.
Note that structure A has no metal ions present (enzyme was
crystallized in the apo form201) and structure C has only one metal
ion present as a result of crystallization conditions (the enzyme
was crystallized in the absence of substrate/product, and under these
conditions, only one metal ion binds).166
Figure 18. Active site structure of the  subunit of E. coli DNA
Pol III complexed with dTMP at (A) pH ) 8.5 and (B) pH ) 5.8.
Only the phosphate moiety of dTMP is shown for clarity. The
phosphate group bidentately coordinates Mn(II) in site M2 or M1
at high or low pH, respectively. The two Mn(II) ions are shown as
purple spheres.
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corresponding site in the 3′-5′ exonuclease from E. coli Pol
I (Figure 17B).
In the high pH structure (Figure 18A), the metal ion in
site M1 is still five-coordinate; however, the phosphate group
of dTMP only interacts with its bridging oxygen atom. The
fifth ligand is a water molecule occupying nearly the same
position as the terminal oxygen atom of the phosphate group
of dTMP in the low pH structure. In contrast, a second
oxygen atom from this phosphate group displaces one of the
water ligands in site 2 in this high pH structure. Both at low
and high pH, the conserved residue His162 plays an
important mechanistic role. At low pH, it is protonated and
hydrogen-bonded to the terminal oxygen ligand from the
bound phosphate group in site M1 (Figure 18B). At high
pH, it is deprotonated and within hydrogen bonding distance
of the water ligand coordinated to site M1, which is expected
to lower the pKa value of this ligand. The mechanistic
implications of this observation will be discussed below.
Similar interaction of substrate/product has been previously
observed in other exonucleases.
Similar coordination geometries have been observed in
other 3′-5′ exonucleases, for example, in the proofreading
activity of Pol I (Figure 17B) and the recently published
structures of the human interferon-induced antiviral ribo-
nuclease ISG20247 and human TREX2.201 The observed
structural similarities in 3′-5′ exonucleases suggest that these
enzymes employ a common catalytic mechanism, outlined
in the next section.
4.3. Catalytic Mechanism
The hydrolysis of nucleic acid diester bonds by 3′-5′
exonucleases results in the formation of a deoxynucleoside
5′-monophosphate and a free 3′-hydroxide group at the
shortened DNA substrate. The following discussion on the
mechanism of 3′-5′ exonucleases is mainly based on recent
insights gained from the crystal structures and kinetic studies
for the  subunit of E. coli Pol III, but since the active site
residues and geometry are conserved, it is likely that the
mechanism shown in Figure 19 is generally valid for this
group of enzymes.189,210,219
In the initial stage of catalysis, a nucleic acid substrate
binds to the active site of the enzyme. Pre-steady-state kinetic
measurements with the  subunit have shown that the
enzyme-DNA complex is formed rapidly, with kf ) 280
s-1.224 Although DNA binding itself is thus not likely to be
the rate-limiting step in the reaction, the structure of the DNA
duplex has a significant effect on the catalytic efficiency of
3′-5′ exonuclease.224 The preferred substrate is single-
stranded DNA; it has been shown that in a series of duplex
DNA oligonucleotides with increasing numbers of mis-
matched base pairs at the 3′-terminus the rate of hydrolysis
increases.224 To accommodate observed catalytic rates, a
model has been proposed that invokes a mechanism, whereby
DNA binds rapidly to the active site in a form that is not
susceptible to hydrolysis.224 Structural rearrangements (DNA
“melting”) lead to activated DNA, termed DNA*, that is the
preferred substrate for 3′-5′ exonuclease. The rate constant
for hydrolysis derived from this model is in good agreement
with rate constants determined for the hydrolysis of single-
stranded DNA substrates.224 The observation that duplex
DNA binds rapidly to the enzyme, but hydrolysis is delayed,
has led to the suggestion that DNA “melting” may be the
rate-limiting step in the proofreading reaction.224 A similar
conclusion has been drawn for the 3′-5′ exonuclease activity
from T4 DNA polymerase based on the pre-steady-state
kinetic studies with matched and mismatched 3′-termini of
the primer-DNA duplex. Different rate constants for matched
(1 s-1) and mismatched 3′-termini of the primers (5 s-1)
implicated “melting” of DNA duplex as the necessary
activation step, that is, the rate-limiting step prior to the fast
exonucleolytic cleavage (100 s-1).248
The precise coordination of the substrate in the active site
is, at least in the  subunit of E. coli Pol III, pH-dependent
(see above).241 In the structure of the subunit -dTMP
complex, determined at pH 8.5, the phosphate group of
dTMP binds with two oxygen atoms to the metal ions: one
bridges the metal ions, and one is terminally bound to the
site 2 metal ion (Figures 18 and 19).241 Importantly, the site
1-coordinated water molecule forms strong hydrogen bonds
with the deprotonated His162 and Glu14 side chain, which
leads to the generation of the reaction-initiating hydroxo
nucleophile (Figure 19A). The significance of His162 is
illustrated by a comparison to 3′-5′ exonuclease from E. coli
Pol I. Instead of a histidine residue, this enzyme has a
Figure 19. Proposed mechanism of hydrolysis by the  subunit of
E. coli DNA Pol III at high pH. (A) Substrate binding; (B)
nucleophilic attack and release of leaving group; (C) regeneration
of the active site; the product-bound state resembles that of the
-dTMP complex at low pH (Figure 18B). Adapted with permis-
sion from ref 189. Copyright 2002 American Chemical Society.
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tyrosine ligand in the equivalent position.158 The higher
basicity of the histidine side chain in the  subunit of E. coli
Pol III is likely to promote formation of a more potent
nucleophile, a proposal that is consistent with the observed
increased reactivity of this enzyme relative to the Pol I 3′-5′
exonuclease.241 Attack by this nucleophile on the phosphorus
leads to the formation of a trigonal-bipyramidal transition
state (Figure 19B). At present, it is not known if bond
formation precedes bond breakage in this mechanism.
However, from the crystal structure of the -dTMP complex,
it has been inferred that following the abstraction of a proton
by Glu14 the transition state collapses to form product
molecules.189,241 It is postulated that a site 2-bound water
molecule acts as proton donor for the leaving alcohol group
(Figure 19B).241 The phosphate group of the deoxynucleoside
5′-monophosphate remains coordinated with two oxygen
atoms to the metal ions. However, while one oxygen is still
bridging, the other one is now terminally bound to the site
M1 center (Figure 19C), in a mode similar to that observed
in the low pH structure of the  subunit complexed with
dTMP (Figure 18B). Hence, the low pH structure appears
to be a good model for the product-bound state of 3′-5′
exonuclease.241
It has been speculated that the role of metal ion M2 (lower
affinity site) is to stabilize the negative charge on the oxygen
atom of the leaving group. Kinetic studies of the 3′-5′
exonuclease domain of E. coli Pol I employing DNA
substrate analogues (deoxyribo-3′-S-phosphorothiolates, where
a sulfur atom replaces the oxygen at the 3′ leaving position)
were carried out in order to probe the reaction mecha-
nism.249,250 These studies have shown that in the presence
of Mg(II) the rate of exonucleolytic cleavage of S-containing
substrates decreased 60 000-fold relative to that of O-
containing substrates, whereas in the presence of Mn(II), the
decrease was only 600-fold. These data represent the first
direct evidence that the low-affinity metal binding site
interacts with the leaving group by stabilizing its negative
charge.250 In addition, crystal structures of the 3′-5′ exo-
nuclease domain of E. coli Pol I complexed with single-
stranded DNA (deoxyribo-3′-S-phosphorothiolates) and Mn(II)
or Zn(II) were consistent with the proposal that the sulfur
atom in the 3′ position of the substrate does affect the binding
of the metal ion in the low-affinity site.251
In the structures of the subunit -dTMP complex,
determined at high and low pH (Figure 18), the phosphate
group of dTMP binds with two oxygen atoms to the metal
ions. One oxygen bridges the metal ions, and one is
terminally bound to one of the two metal ions, site 2 or site
M1, respectively (Figures 18 and 19).241 Thus, at low pH,
substrate binding may displace the proposed nucleophile at
site M1 (see above). Instead, a site M2-bound water
molecule, activated via a hydrogen bonding interaction with
Asp103, has been proposed to act as the nucleophile (Figure
18).189 Thus, in the proposed mechanisms at low and high
pH, crucial roles for residues Asp103 and His162 are invoked
for the activation of proposed nucleophiles, a hypothesis
which awaits further substantiation via site-directed mu-
tagenesis studies. The proposed pH dependence of the
catalytic mechanism of the  subunit of E. coli Pol III is
reminiscent of pH-mediated changes in the reaction cycle
of some PAPs. For both sweet potato and proteolytically
cleaved (activated) human PAPs, evidence has accumulated
that supports a model where the identity of the proton donor
for the leaving group depends on pH (see above).56,64
5. 5′-Nucleotidases
5.1. Biochemical Characterization and Function
5′-NT (E.C. 3.1.3.5) is a member of the calcineurin super-
family (see section 3) of binuclear metallophosphatases252,253
and catalyzes the dephosphorylation of ribo- and deoxyribo-
nucleoside 5′-monophosphates to the corresponding nucleo-
sides, thus, forming the catabolic arm responsible for
maintaining balanced nucleotide pools.254
5′-NTs have been isolated from numerous sources, includ-
ing multiple mammalian species,254-258 birds,259 arthropods,260
reptiles,261 plants,262,263 and bacteria.264-266 In animals, two
types of 5′-NTs are present, but of these, only one form,
labeled ecto-5′-NTs, has a binuclear center.254,255 Ecto-5′-
NTs are typically bound to the outer surface of the plasma
membrane with their C-terminus anchored via a glyco-
sylphosphatidylinositol (GPI) group, but have also been
isolated in soluble form.267,268 The amino acid sequences of
mammalian ecto-5′-NTs are highly conserved, with an
identity of greater than 85%.268 In bacteria, different forms
of 5′-NT have also been identified.264-266,269 A majority of
these enzymes seem to be binuclear systems,264,266 and
although the overall sequence homology between homo-
dimeric mammalian ecto-5′-NT and the monomeric bacterial
enzymes is low, their active site and substrate binding
residues are conserved.255,270
The best-characterized 5′-NT to date is the E. coli enzyme.
65Zn enrichment of the growth medium indicated that E. coli
5′-NT contains at least one tightly bound zinc atom.271
Similarly, metal ion analyses of 5′-NT purified from bull
seminal plasma, chicken gizzard, and snake venom have
shown these enzymes to contain at least one zinc atom per
active site.261 Interestingly, the Co(II) derivative of the
enzyme is most active.264,272 Other divalent metals, including
manganese and magnesium, also promote activity,264,272,273
while an excess of zinc has an inhibitory effect.264 Similar
to PAPs, the metal ion composition does affect not only
reactivity, but also the pH dependence of kinetic param-
eters.254,264,273 For E. coli 5′-NT with AMP as the substrate,
the optimal pH varies from 8.0 with manganese to 6.0 with
a mixture of cobalt and calcium.264,273 The pH dependence
is also governed to some extent by the nature of the
substrate.273 For di- and triphosphates, the optimum pH range
is broad, ranging between pH 5.5 and 8.5. The ecto-5′-NTs
derived from chicken gizzard and rat liver exhibit a pH
optimum of 7.5,259,274 while other enzymes exhibit broader
pH optima: pH 6.8-8.0 for the rat renal enzyme275 and pH
8.0-9.0 for guinea pig skeletal muscle enzyme.254,276
E. coli 5′-NT hydrolyzes all 5′-ribo- and 5′-deoxyribo-
nucleotides (including di- and triphosphates), with a prefer-
ence for AMP.252,264,273 The enzyme also hydrolyzes uridine
diphosphate sugars260,272 and the synthetic substrates bis-p-
nitrophenyl phosphate and p-nitrophenyl phosphate (p-NPP),
which are widely used to assay enzyme activities in metallo-
hydrolases.253,258,260 The animal ecto-5′-NTs are more spe-
cific. AMP is purported to be the major physiological
substrate, and ADP and ATP are competitive inhibitors of
AMP hydrolysis.255,276 Additionally, ecto-5′-NTs do not
hydrolyze p-NPP.258 Inhibitors of the 5′-NTs include ad-
enosine 5′-[R,â-methylene]diphosphate (AMPCP)254,277,278
and concanavalin A,254,276 but phosphate has no inhibitory
effect.268 The selective inhibition by ATP and ADP of di-
but not monoesterase activity in E. coli 5′-NT has been
interpreted in terms of two substrate binding sites, a catalytic
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site with high affinity and an inhibitory site with low affinity
for substrate.279 The presence of two distinct substrate binding
sites may also account for the observed deviation of E. coli
5′-NT from common Michaelis-Menten behavior, sug-
gesting uncompetitive substrate inhibition.253,264,273,279,280
This deviation is not observed in enzymes from other
sources.275,277,281
The precise biological role(s) of 5′-NTs is still obscure.
In bacteria, these enzymes are believed to play a role in the
hydrolysis of extracellular nucleoside diphosphate sugars to
nucleosides and nonphosphorylated sugar products which are
readily transported into the cell, thus, providing a carbon
source for the cell.258 The activity of 5′-NTs within E. coli
cells is repressed by a protein inhibitor, possibly to prevent
the disruption of nucleic acid metabolism.252,269,272,282
Ecto-5′-NTs are present in most animal tissues,258 and have
been proposed to play a key role in nucleotide salvage by
dephosphorylating oxy- and deoxynucleotides. The abun-
dance of extracellular adenine nucleotides and the high
affinity of ecto-5′-NTs for AMP suggest that adenosine is
the major nucleoside produced by ecto-5′-NTs. However,
other extracellular nucleotides are also dephosphorylated by
this enzyme, albeit with decreased efficiency.254
Additionally, ecto-5′-NTs have been ascribed a role in the
inactivation of ATP, and the formation of adenosine,254 which
may be of particular importance in controlling the function
of ATP as an intercellular messenger.258 In the final step of
ATP inactivation, ecto-5′-NTs catalyzes the dephosphoryl-
ation of AMP to adenosine, which can interact with specific
receptors to induce an array of physiological functions
including vasodilation, lipolysis, a decrease in glomerular
filtration rate, the inhibition of renin release, and the
inhibition of both neurotransmitter release and immune/
inflammatory response.258,283 Although ecto-5′-NT may not
be the only enzyme that is involved in the generation of
extracellular adenosine, there is evidence that its expression
and activity is functionally associated with adenosine receptor
activation.284-286 Its preference for AMP implicates ecto-5′-
NT in a wide range of physiological functions,258 suggesting
a possible role as a drug target.
5.2. Structural Characterization
The crystal structure of E. coli 5′-NT has been deter-
mined.287,288 It is a monomeric protein consisting of an
N-terminal domain linked via an R-helix to a smaller
C-terminal domain (Figure 20). There are relatively few
interactions between the two domains, and they are separated
by a layer of water molecules.288 The substrate binding pocket
is located on the C-terminal domain, while the binuclear
active site is situated on the N-terminal domain, close to the
domain interface within a cleft approximately 20 Å deep and
15-17 Å wide.253,287
The active site contains two Zn(II) ions and has a positive
electrostatic potential, attracting negatively charged phospho-
ester substrates to the active site.287 The zinc ions are 3.3 Å
apart and, similar to PAPs, bridged monodentately by Asp84
and by either a water molecule or an adventitious bicarbonate
or acetate ion (Figure 21).287 The zinc ions are five-
coordinate, with trigonal bipyramidal geometry.287 Site M1
(Figure 21) has Zn also coordinated by two oxygen atoms
from Asp41 and Gln254 and one nitrogen atom from His43
and represents the site with high affinity for the metal ion
(i.e., this site is equivalent to the chromophoric Fe(III)-
binding site in PAPs).280 Site M2 (Figure 21) is coordinated
to the nitrogen atoms of two histidine residues (His217 and
His252) and an asparagine oxygen atom (Asn116). The
metal-ligating residues and the catalytic histidine are highly
conserved both between 5′-NTs from different sources and
in a number of other phosphoesterases, including PAPs and
PPPs.11,21,287 Also shown in Figure 21 is the catalytic
His117-Asp120 dyad. Site-directed mutagenesis studies
have also invoked a catalytic role for the second coordination
sphere residue Glu118 (the Glu118Gln mutant is only 6%
as active as the wild-type), although its precise function in
the active site remains to be determined.280
The structure of E. coli 5′-NT has also been determined
in the presence of the bound ADP analogue AMPCP, ATP,
and the reaction products adenosine and phosphate. In the
presence of AMPCP, the active site contains two Mn(II) ions
due to inclusion of manganese in the crystallization solu-
tion.270 The metal ions are six-coordinate in an octahedral
Figure 20. Ribbon diagram depicting the overall fold of E. coli
5′-NT in complex with (A) ATP and (B) AMPCP (PDB codes 1HP1
and 1HPU, respectively). The N-terminal domain is green, the
C-terminal domain is blue, the domain-linking helix is blue, and
the metal ions are silver. Adapted with permission from ref 288.
Copyright 2001 Elsevier Publishing.
Figure 21. The active site of E. coli 5′-NT. In the absence of
substrate analogues or products, the two metal centers are five-
coordinate. Adventitious carbonate (or acetate) is present as a
consequence of the crystallization conditions.287
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environment, bound to the seven amino acid ligands shown
in Figure 21, in addition to two water molecules and one of
the phosphate oxygen atoms (coordinated to Mn2, which
corresponds to Zn2 in Figure 21). One of the water/hydroxide
molecules bridges the two metal ions, while the other is
terminally bound to Mn1 (corresponding to Zn1). Thus, the
active site geometry is similar to that observed for rat PAP
in the presence of bound sulfate (see section 2).67 The
structure of the substrate analogue/inhibitor-protein com-
plexes indicate that the substrate binding pocket for nucleo-
tides is mainly formed by residues in the C-terminal domain,
while N-terminal amino acids provide most of the catalytic
residues.270 Substrate binding is facilitated predominantly by
a hydrophobic stacking interaction between the ADP ana-
logue and the aromatic residues of Phe429 and Phe491.270
The comparison between 5′-NT structures with bound
AMPCP and ATP identified two distinct structural confor-
mations.288 In the open form (ATP-bound structure; Figure
20A), the substrate binding pocket is 25 Å distant from
the catalytically active site. In the closed form, both the
substrate binding pocket and the active site are situated in
close proximity at the domain interface (AMPCP-bound
structure; Figure 20B). The domain-connecting R-helix acts
as a hinge region facilitating the 96° rotation required to
toggle between open and closed conformations.288 The
significance of domain rotation for catalysis has been
demonstrated in two variants of E. coli 5′-NT with fixed
open (5′-NT-O) or closed (5′-NT-C) conformation.289 As
expected, 5′-NT-O is unable to hydrolyze AMP. In contrast,
5′-NT-C is approximately half as active as the wild-type
enzyme. The residual activity has been ascribed to partial
interdomain rotation (43.2°), presumably enabling substrate
binding, but with decreased efficiency.253
5.3. Catalytic Mechanism
The bulk of mechanistic studies of 5′-NTs have been
focused on the E. coli enzyme, but since all but one of the
catalytically relevant residues are conserved, the general
features of the reaction mechanism are anticipated to be
similar in the nonbacterial 5′-NTs.252
In the initial step of the reaction cycle, the enzyme is in
the open conformation allowing unhindered access for the
substrate to the C-terminal domain containing the substrate
binding pocket. A structural comparison by circular dichro-
ism between resting wild-type E. coli 5′-NT and the 5′-NT-O
mutant strongly suggests an open conformation for the former
in solution.253 Subsequently, substrate binding induces con-
formational change via domain rotation, thus, positioning the
substrate in the interdomain region adjacent to the active site.
In the second step of catalysis, the phosphate group is
proposed to bind monodentately to the low-affinity metal
ion (site M2 in Figures 21 and 22). Hydrogen bonding
interactions between the phosphate group and the side chains
of His117 and Arg410 ensure optimal orientation of the
substrate for attack by a nucleophile (Figure 22A). The
precise identity of this nucleophile is subject to debate, with
two metal-bound water molecules (one bridging the metal
ions and one terminally bound to the metal ion in site M1;
Figure 22B) proposed as likely candidates.270,288 In accord
with the E. coli 5′-NT crystal structure with bound AMPCP
(Figure 20B), the water molecule coordinated terminally to
site M1 is 3.2 Å distant from the phosphorus atom of the
substrate and in an ideal position for an in-line nucleophilic
attack with an O(N)-P-O(R) angle of 155° (O(N) and O(R)
represent oxygen atoms of the nucleophile and the leaving
group, respectively).252,270 The pKa values reported for Zn(II)-
bound water molecules in a range of model complexes
Figure 22. Proposed mechanism of hydrolysis by E. coli 5′-NT.
(A) Substrate binding; (B) nucleophilic attack and release of leaving
group; (C) regeneration of the active site (see text for details).
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depend strongly on the coordination environment and range
from 7.3 to 10.8.290-296 Since E. coli 5′-NT is an efficient
catalyst even at pH 6, it seems likely that the pKa of the
terminal water molecule is lowered through hydrogen bond-
ing interactions with His117 (Figure 22A). The pH depen-
dence of kinetic parameters for 5′-NT-catalyzed reactions
has not yet been analyzed in detail, but based on pH optima
ranging from 5.5 to 9 for different enzymes, it appears that
in some 5′-NTs the likely candidate for the role of a
nucleophile is the bridging water ligand, which is expected
to have a lower pKa value.292,297
Similar to the other binuclear metallohydrolases, the
transition state is proposed to be a pentacoordinated phos-
phoryl species stabilized by hydrogen bonding interactions
with the side chains of Asn116, His117, and Arg410.270 Since
no general acid is positioned appropriately for protonation
of the leaving group, a role for a solvent water molecule as
the proton donor has been invoked.270 After hydrolysis, the
tetrahedral phosphate ion remains bound to the active site
in a bidentate fashion (Figure 22C), as observed in the crystal
structures of pig and red kidney bean purple acid phos-
phatases.63,65 The release of the leaving group is presumably
assisted by a structural rearrangement, which returns the
protein to its open conformation. This latter step offers an
explanation for the observed substrate inhibition, since
substrate molecules bound to a low-affinity, inhibitory site
may prevent domain rotation and thus the release of reaction
products.253
In the final step of the catalytic cycle, phosphate is
removed and the catalytic site is regenerated for the next
cycle. The crystal structure of E. coli 5′-NT complexed with
phosphate and adenosine indicates that phosphate may
change its coordination from bi- to monodentate prior to
being released.270 In the crystal structure of the dizinc enzyme
in the resting state, both metals are five-coordinate and no
terminal water ligand is present,287 and at present, it is
uncertain when the terminally bound water ligand enters the
active site.
6. Conclusions
The family of binuclear metallohydrolases contains several
members which have been recognized as potential targets
for the development of chemotherapeutics and promising
candidates in bioremediation (Table 1). Understanding the
factors that contribute to the observed mechanistic versatility
of these systems is not only essential in understanding how
these enzymes catalyze reactions, but is also critical in the
design and development of potent and selective pharmaceu-
ticals. This article has focused on four specific binuclear
metallohydrolases, PAPs, PPs, 3′-5′ exonucleases, and 5′-
NTs, which are experimentally well-developed systems
showing the geometric and electronic structures of active
sites and transition states for these binuclear metal centers.
Other enzymes, which we have not alluded to, but which
have comparable binuclear metal centers, include the Ni(II)-
dependent ureases,88,298-301 phosphotriesterases,302,303 and
aminopeptidases304-308 and nucleases such as the DNA
double-strand break repair enzyme Mre11246,309 and the UDP-
galactose:â-galactoside-R-1,3-galactosyltransferase.310 In ad-
dition, global efforts into the sequencing and annotation of
genomes are continually revealing other novel binuclear
metalloenzymes. Examples are a recently characterized
phosphodiesterase from M. jannaschii311 and a vacuolar
protein sorting protein from human.312
Another group of binuclear metalloenzymes with great
pharmacological potential is the metallo-â-lactamase family.
â-Lactamases are of profound importance due to their ability
to hydrolyze, and thus inactivate, â-lactam antibiotics. Of
these, the metallo-â-lactamases are a major concern, since
they hydrolyze virtually all known â-lactams and because
there are no efficient inhibitors known to date.313,314 Crystal
structures of several members of the metallo-â-lactamase
superfamily have been solved recently.315-319 The structure
of the zinc-dependent â-lactamase from Fluoribacter gor-
manii (FEZ-1) shows that the aspartate residue coordinated
terminally to one of the zinc ions in the active site (Asp120)
forms a hydrogen bond with the bridging water molecule,
thus, activating the latter for its role as a nucleophile.317,319
Site-directed mutagenesis studies in the related metallo-â-
lactamase L1 from Stenotrophomonas maltophiliac have
further lent support to the catalytic role of this aspartate
residue; specifically, it has been suggested that it positions
the bridging nucleophile suitably for catalysis.314 This
hydrogen bond interaction between a terminal aspartate
ligand and a bridging water molecule is a common
feature among the structurally characterized metallo-â-
lactamases,315-319 which is also observed in PPMs. A similar
hydrogen bonding interaction is established via a backbone
carbonyl oxygen atom from a histidine ligand for PAPs and
PPPs (see sections 2 and 3). Also of interest is the
observation that FEZ-1, unlike most binuclear metallo-
hydrolases, does not have a metal ion-bridging amino acid
ligand, while one member of the metallo-â-lactamase family
(rubredoxin:oxygen oxidoreductase (ROO) from DesulfoVibrio
gigas316) has a bridging aspartate ligand in the í-1,3
coordination mode like PPMs and 3′-5′ exonuleases, and
three others (human gloxylase II (GOX), RNase Z from B.
subtilis, and the phosphorylcholine esterase (Pce) domain
of the virulence factor choline-binding protein E315,318,319)
have an aspartate residue in a í-1,1 coordination mode, as
observed in PAPs, PPPs, and 5′-NTs. Furthermore, in RNase
Z and Pce, the active sites in the presence of phosphate are
very similar to those of pig and red kidney bean PAPs with
a í-1,3 coordination of phosphate. Little is currently known
about the specific metal ion requirements of metallo-â-
lactamases, but ROO requires iron to catalyze its redox
reactions,316 while GOX appears to be more flexible with
iron, manganese, and zinc present in the active site.320,321
Ultimately, it will be interesting to investigate the detailed
catalytic mechanisms of metallo-â-lactamases and compare
them with those of the enzymes reviewed here.
The binuclear metallohydrolases discussed in this review
illustrate both mechanistic similarities, and functional varia-
tions. The latter is a reflection of the evolutionary adaptation
for a specific task. In particular, active sites have optimized
geometries to accommodate specific substrates. Mechanistic
similarities include that each enzyme requires two metal ions
and a metal ion-bound water molecule (hydroxide or oxide)
for activity. Correspondingly, catalysis is accompanied by
an inversion of the stereochemistry of the phosphate group.
This observation is the main feature that distinguishes these
enzymes from alkaline phosphatases (Table 1), which utilize
a serine ligand as nucleophile and thus form phospho-enzyme
reaction intermediates.6,322,323
In summary, key features of the mechanism of metallo-
hydrolase-catalyzed reactions include the mode of binding
of the substrate, the identity of the nucleophile, the release
of the leaving group, and the regeneration of the active site.
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Recent structures incorporating substrate analogues or inhibi-
tors such as sulfate, tungstate, and phosphate have provided
snapshots of distinct catalytic steps, particularly for PAPs.
While still the subject of conjecture, it appears that in some
metallohydrolases, including PAPs and PPs, the substrate
may form a í-1,3 precatalytic complex, while in others (e.g.,
5′-NTs), the phosphate group of the substrate binds only to
one metal ion prior to the nucleophilic attack.
The precise identity of the nucleophile also remains
conjectural, although recent spectroscopic and crystallo-
graphic data favor a bridging hydroxide/oxo group for PAPs.
Similar conclusions were drawn for PPs (both PPPs and
PPMs), while proposed models for the mechanism of 3′-5′
exonucleases and 5′-NTs tend to prefer a terminally bound
water molecule as nucleophile (alkaline phosphatases utilize
a serine residue as nucleophile322,323).
For pig and red kidney bean PAPs, as well as PPPs and
alkaline phosphatases, a (partial) dissociative mechanism is
likely to operate, while sweet potato and activated human
PAPs appear to follow an associative mechanism. For 3′-5′
exonucleases, 5′-NTs, and several other metallohydrolases
listed above, the formation of a pentacoordinated phosphoryl
transition state has been proposed, but at present, it is not
known if bond formation precedes bond breakage.
The final stage of the mechanism involves regeneration
of the active site for the next cycle by displacement of the
bound phosphate group, replacement of aqua ligands (bridg-
ing or terminal), and, in some instances, protonation of
proposed proton donors. Especially for PPMs, this last step
in catalysis has been proposed to be rate-limiting.
In conclusion, the broad features of catalysis are conserved
across the four different enzymes systems, but there are
significant differences which emerge when each is probed
by various physicochemical techniques currently available.
Furthermore, this review has illustrated gaps in our current
understanding of the mechanisms of binuclear metallo-
hydrolase-catalyzed reactions. It is hoped that the interested
reader may find this article stimulating to address these
issues.
7. Abbreviations
AMPCP adenosine 5′-[R,â-methylene]diphosphate
Ape apurinic/apyrimidinic endonuclease
BDNPP 2,4-bis(dinitrophenyl) phosphate
dTMP deoxythymidine 5′-monophosphate
ENDOR electron-nuclear double resonance
EPR electron paramagnetic resonance
EXAFS X-ray absorption fine structure
GPI glycosylphosphatidylinositol
NHE normal hydrogen electrode
5′-NT 5′-nucleotidase
PAP purple acid phosphatase
pNPP para-nitrophenyl phosphate
PP Ser/Thr protein phosphatase
rmsd root-mean-square deviation
ROS reactive oxygen species
TREX 3′-repair exonuclease
V-TREX viral 3′-repair exonuclease
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